<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dressings for superficial and partial thickness burns - Wasiak, J - 2013 | Cochrane Library</title> <meta content="Dressings for superficial and partial thickness burns - Wasiak, J - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002106.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dressings for superficial and partial thickness burns - Wasiak, J - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002106.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD002106.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Dressings for superficial and partial thickness burns" name="citation_title"/> <meta content="Jason Wasiak" name="citation_author"/> <meta content="Monash University, The Alfred Hospital" name="citation_author_institution"/> <meta content="J.Wasiak@alfred.org.au" name="citation_author_email"/> <meta content="Heather Cleland" name="citation_author"/> <meta content="The Alfred Hospital" name="citation_author_institution"/> <meta content="Fiona Campbell" name="citation_author"/> <meta content="University of Sheffield" name="citation_author_institution"/> <meta content="Anneliese Spinks" name="citation_author"/> <meta content="Griffith University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD002106.pub4" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/03/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002106.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002106.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002106.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Wound Healing; Bandages [classification, *standards]; Bandages, Hydrocolloid; Burns [physiopathology, *therapy]; Randomized Controlled Trials as Topic; Silicon Compounds [therapeutic use]; Silver Sulfadiazine [therapeutic use]; Skin, Artificial" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002106.pub4&amp;doi=10.1002/14651858.CD002106.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="f00EizoA";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002106\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002106\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fr","pt","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD002106.pub4",title:"Dressings for superficial and partial thickness burns",firstPublishedDate:"Mar 28, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Wounds Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002106.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002106.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD002106.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD002106.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002106.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD002106.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002106.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD002106.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD002106.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002106.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17296 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD002106.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-sec-0173"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-sec-0041"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-sec-0042"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-sec-0172"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/appendices#CD002106-sec-0178"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/table_n/CD002106StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/table_n/CD002106StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dressings for superficial and partial thickness burns</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information#CD002106-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jason Wasiak</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information#CD002106-cr-0003">Heather Cleland</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information#CD002106-cr-0004">Fiona Campbell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information#CD002106-cr-0005">Anneliese Spinks</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information/en#CD002106-sec-0187">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 March 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD002106.pub4">https://doi.org/10.1002/14651858.CD002106.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD002106-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002106-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002106-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002106-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002106-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002106-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD002106-abs-0001" lang="en"> <section id="CD002106-sec-0001"> <h3 class="title" id="CD002106-sec-0001">Background</h3> <p>An acute burn wound is a complex and evolving injury. Extensive burns produce systemic consequences, in addition to local tissue damage. Treatment of partial thickness burn wounds is directed towards promoting healing and a wide variety of dressings are currently available. Improvements in technology and advances in understanding of wound healing have driven the development of new dressings. Dressing selection should be based on their effects on healing, but ease of application and removal, dressing change requirements, cost and patient comfort should also be considered. </p> </section> <section id="CD002106-sec-0002"> <h3 class="title" id="CD002106-sec-0002">Objectives</h3> <p>To assess the effects of burn wound dressings on superficial and partial thickness burns. </p> </section> <section id="CD002106-sec-0003"> <h3 class="title" id="CD002106-sec-0003">Search methods</h3> <p>For this first update we searched The Cochrane Wounds Group Specialised Register (searched 8 November 2012); The Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2012, Issue 10); Ovid MEDLINE (2008 to October Week 4 2012); Ovid MEDLINE (In‐Process &amp; Other Non‐Indexed Citations, November 07, 2012); Ovid EMBASE (2008 to 2012 Week 44); AND EBSCO CINAHL (1982 to 2 November 2012). </p> </section> <section id="CD002106-sec-0004"> <h3 class="title" id="CD002106-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs) that evaluated the effects of burn wound dressings on the healing of superficial and partial thickness burns. </p> </section> <section id="CD002106-sec-0005"> <h3 class="title" id="CD002106-sec-0005">Data collection and analysis</h3> <p>Two authors extracted the data independently using standardised forms. We assessed each trial for internal validity and resolved differences by discussion. </p> </section> <section id="CD002106-sec-0006"> <h3 class="title" id="CD002106-sec-0006">Main results</h3> <p>A total of 30 RCTs are included in this review. Overall both the quality of trial reporting and trial conduct were generally poor and meta analysis was largely precluded due to study heterogeneity or poor data reporting. In the context of this poor quality evidence, silver sulphadiazine (SSD) was consistently associated with poorer healing outcomes than biosynthetic (skin substitute) dressings, silver‐containing dressings and silicon‐coated dressings. Burns treated with hydrogel dressings appear to heal more quickly than those treated with usual care. </p> </section> <section id="CD002106-sec-0007"> <h3 class="title" id="CD002106-sec-0007">Authors' conclusions</h3> <p>There is a paucity of high‐quality evidence regarding the effect of different dressings on the healing of superficial and partial thickness burn injuries. The studies summarised in this review evaluated a variety of interventions, comparators and clinical endpoints and all were at risk of bias. It is impossible to draw firm and confident conclusions about the effectiveness of specific dressings, however silver sulphadiazine was consistently associated with poorer healing outcomes than biosynthetic, silicon‐coated and silver dressings whilst hydrogel‐treated burns had better healing outcomes than those treated with usual care. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD002106-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002106-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002106-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002106-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002106-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD002106-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD002106-abs-0010">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002106-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD002106-abs-0005" lang="en"> <h3>Dressings for treating superficial and partial thickness burns</h3> <p>Superficial burns are those which involve the epidermal skin layer and partial thickness burns involve deeper damage to structures such as blood vessels and nerves. There are many dressing materials available to treat these burns but none has strong evidence to support their use. Evidence from poor quality, small trials, suggests that superficial and partial thickness burns heal more quickly with silicon‐coated nylon, silver containing dressings and biosynthetic dressings than with silver sulphadiazine cream. Burns treated with hydrogel dressings healed more quickly than those treated with usual care. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD002106-sec-0173" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD002106-sec-0173"></div> <h3 class="title" id="CD002106-sec-0174">Implications for practice</h3> <section id="CD002106-sec-0174"> <p>A number of dressings may have some benefits over alternatives for the management of superficial and partial thickness burns. There is some, albeit poor quality, research evidence to suggest that silver‐based dressings, silicon‐coated nylon and biosynthetic dressings are associated with better healing outcomes than SSD. Hydrogel dressings were associated with better healing outcomes than usual care. </p> </section> <h3 class="title" id="CD002106-sec-0175">Implications for research</h3> <section id="CD002106-sec-0175"> <p>There is a need for large, well‐designed trials for dressing interventions. There is a need to clearly estimate burn depth in order to use properly defined dressing interventions. Trials should address key methodological criteria (allocation concealment, blinding of participants and outcome assessors, adequate follow‐up and appropriate statistical analysis) and should follow CONSORT guidelines on reporting. The review did not conduct an economic analysis and that would usefully inform decisions about the most effective and cost‐effective treatments for patients with burn wounds. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD002106-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD002106-sec-0029"></div> <section id="CD002106-sec-0030"> <h3 class="title" id="CD002106-sec-0030">Description of the condition</h3> <p>Burn injury occurs in all age groups, from many causes, and may range from the very minor, when no or self treatment is sufficient, through to the most severe which require the highest levels of intensive care and surgery. Thus, patients suffering a burn injury present with a wide spectrum of injury severity depending on the depth of the wound and the surface area of the body affected. This variability of injury makes it difficult to describe the number of people who suffer burn injuries each year accurately; only the most serious are admitted to hospital and these are the least common of burn injuries (<a href="./references#CD002106-bbs2-0059" title="BurdA , YuenC . A global study of hospitalized paediatric burn patients. Burns2005;31(4):432‐8. ">Burd 2005</a>). </p> <p>Full thickness burns involve all layers of the skin and may involve the structures beneath such as muscle and bone. A superficial burn involves just the epidermal layer of the skin, while partial thickness burns involve damage to deeper structures within the skin such as blood vessels, nerves and hair follicles. Whilst causing considerable pain and distress, these types of burns can heal without the need for surgical intervention and, if only involving relatively small areas, can be managed safely in an outpatient environment. It is these types of burn wounds that are the focus of this review. </p> <p>Accurate assessment of burn depth is important in making the right decision about treatment. Most extensive burns are a mixture of different depths and burn depth can change and deepen following initial injury (<a href="./references#CD002106-bbs2-0063" title="HettiaratachyS , PapiniR . Initial management of a major burn: II ‐ assessment and resuscitation. BMJ2004;329(7457):101‐3. ">Hettiaratachy 2004</a>). The management of burn wounds can have a considerable influence on the time taken for the wound to heal. Ensuring that the wound is managed in a way that promotes healing will influence the long term quality and appearance of the scar, and also minimise the risk of burn wound infection. Superficial and partial thickness wounds can progress to a deeper burn if the wound dries out or becomes infected. </p> </section> <section id="CD002106-sec-0031"> <h3 class="title" id="CD002106-sec-0031">Description of the intervention</h3> <p>Numerous dressing materials are available for treating partial thickness burns, the most common being a combination of paraffin‐impregnated gauze and an absorbent cotton wool layer (<a href="./references#CD002106-bbs2-0066" title="HudspithS , RayattS . First aid and treatment of minor burns. BMJ2004;328(7454):1487‐9. ">Hudspith 2004</a>). Silver sulphadiazine (SSD) cream has also been commonly used in burn wound management since 1968 to minimise the risk of wound infection. However, these conventional dressings tend to adhere to the wound surface (<a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>) and their need for frequent changes traumatises newly epithelialised surfaces and delays healing. Silver sulphadiazine cream itself is also thought to delay wound healing due to a toxic effect on regenerating keratinocytes (<a href="./references#CD002106-bbs2-0073" title="WasiakJ , ClelandH . Minor thermal burns. Clinical Evidence. BMJ Publishing Group, 2005. ">Wasiak 2005</a>). </p> <p>The limitations of conventional dressings, improvements in technology and advances in our understanding of wound healing have led to an enormous expansion in the range of dressing options that can be used on minor burns. Burn wounds may lose large amounts of fluid through evaporation and exudation, so dressings must absorb fluid, but also maintain a high humidity at the wound site to encourage granulation and assist epithelialisation. The burn dressing should provide a bacterial barrier to prevent infection entering the wound or being transmitted from the wound. Burn dressings should also possess mechanical characteristics to accommodate movement (<a href="./references#CD002106-bbs2-0070" title="QuinnKJ , CourtneyJH , EvansJH , GaylorJDS , ReidWH . Principles of burn dressings. Biomaterials1985;6(6):369‐77. ">Quinn 1985</a>) </p> <p>The range of dressings now available can be sub‐categorised into different types based upon the materials used in their manufacture (<a href="./references#CD002106-bbs2-0069" title="QueenD , EvansJH , GaylorJDS , CourtneyJM , ReidWH . Burn wound dressings ‐ a review. Burns1987;13(3):218‐28. ">Queen 1987</a>). These sub‐categories can include: films, foams, composites, sprays and gels. Also available as an alternative to traditional gauze dressings are the biological skin replacements and the bioengineered skin substitutes, including autologous cultured and non‐cultured products, and the newer biosynthetic skin dressings that are available to produce physiological wound closure until the epidermal layer has repaired. Further details of these dressing categories are as follows: </p> <section id="CD002106-sec-0032"> <h4 class="title">1. Hydrocolloid dressings</h4> <p>Hydrocolloid dressings contain a variety of constituents including gelatin, pectin and sodium carboxymethylcellulose in an adhesive polymer matrix. These dressings form a gel when their inner layer comes into contact with exudate which in turn facilitates autolytic debridement of the wound. Examples of a hydrocolloid dressing include Comfeel (Coloplast) and DuoDerm (ConvaTec) (<a href="./references#CD002106-bbs2-0067" title="LawrenceFC . Dressing for burns. In: FlanaganM editor(s). Wound Management. Churchill Livingstone, 1997. ">Lawrence 1997</a>). </p> </section> <section id="CD002106-sec-0033"> <h4 class="title">2. Polyurethane film dressings</h4> <p>Polyurethane films are transparent, adhesive‐coated sheets that are applied directly to the wound. They are permeable to water vapour, oxygen and carbon dioxide but not to liquid water or bacteria. Depending on the amount of wound exudate, the dressings can be left in place for several days. Film dressings are suitable for lightly exuding wounds (<a href="./references#CD002106-bbs2-0067" title="LawrenceFC . Dressing for burns. In: FlanaganM editor(s). Wound Management. Churchill Livingstone, 1997. ">Lawrence 1997</a>). Two examples of a polyurethane film include OpSite (Smith &amp; Nephew) or Tegaderm (3M Company). </p> </section> <section id="CD002106-sec-0034"> <h4 class="title">3. Hydrogel dressings</h4> <p>Hydrogel dressings are high water content gels containing insoluble polymers. Their constituents include modified carboxymethylcellulose, hemicellulose, agar, glycerol and pectin. Unlike the film dressings, they have more capacity to absorb fluid, and can therefore cope with higher levels of wound exudate. Their fluid donating properties may also aid wound debridement and assist in maintaining a moist wound environment. Hydrogels are available in amorphous form (a loose gel) and in a sheet form where the gel is presented with a fixed three‐dimensional macro structure. Amorphous hydrogels include products such as IntraSite (Smith &amp; Nephew) and Solugel, while sheet hydrogels include Aqua clear and Nu‐gel (Johnson &amp; Johnson). </p> </section> <section id="CD002106-sec-0035"> <h4 class="title">4. Silicon‐coated nylon dressings</h4> <p>This group of dressings consist of a flexible polyamide net coated with soft silicone containing no biological compounds. They act as a direct wound contact layer and their mesh structure allows drainage of exudate from the burned surface. They function primarily as a non‐adherent dressing layer and therefore to reduce potential damage during dressing changes. An example includes Mepitel (Mölnlycke)(<a href="./references#CD002106-bbs2-0072" title="WalmsleyS . Advances in Wound Management. PJB Publications Ltd, 2002. ">Walmsley 2002</a>). </p> </section> <section id="CD002106-sec-0036"> <h4 class="title">5. Biosynthetic skin substitute dressings</h4> <p>Biosynthetic skin substitute dressings are a family of materials which have been developed to mimic a function of skin by replacing the epidermis or dermis, or both. Generally speaking, manufactured epidermal substitutes will allow for re‐epithelialisation to occur while permitting a gas and fluid exchange which in turn provides both protection from bacterial influx and mechanical coverage (<a href="./references#CD002106-bbs2-0061" title="DemlingRH , deSantiL , OrgillDP . Skin substitutes. Section 12. http://216.92.122.69/Modules/skinsubstitutes/sec12.htm (accessed 7 February 2013). ">Demling 2013</a>). Examples include Biobrane (Dow Hickam/Bertek Pharmaceuticals) and TransCyte (Advanced Tissue Sciences) (<a href="./references#CD002106-bbs2-0072" title="WalmsleyS . Advances in Wound Management. PJB Publications Ltd, 2002. ">Walmsley 2002</a>). </p> </section> <section id="CD002106-sec-0037"> <h4 class="title">6. Antimicrobial (silver and iodine‐containing) dressings</h4> <p>Antimicrobial dressings claim to manage the bio burden of the wound: they are thought to reduce the risk of invasive infection by minimising the bacterial colonisation of wounds. Specialist products containing antimicrobials include the Acticoat range (delivering nano‐crystalline silver) and the Iodosorb range (cadexomer iodine). Several types of product have now been produced with added silver, including: Contreet (hydrocolloid with silver), Avance (foam with silver) and Aquacel Ag (fibre dressing with silver, ConvaTec). </p> </section> <section id="CD002106-sec-0038"> <h4 class="title">7. Fibre dressings</h4> <p>Fibre dressings such as the calcium alginate dressings are absorbent, biodegradable and derived from seaweed. Alginate dressings may help to maintain a moist microenvironment conducive to healing, whilst limiting wound secretions and minimising bacterial contamination. They are useful for moderate to heavily exudating wounds. Alginates can be rinsed away with saline irrigation, which minimises interference with the healing process and may reduce pain experienced by patients. Some examples of alginate dressings are: Algosteril (Johnson &amp; Johnson), Comfeel Alginate Dressing (Coloplast), Carrasorb H (Carrington Laboratories), Kaltostat (ConvaTec) (<a href="./references#CD002106-bbs2-0072" title="WalmsleyS . Advances in Wound Management. PJB Publications Ltd, 2002. ">Walmsley 2002</a>). </p> </section> <section id="CD002106-sec-0039"> <h4 class="title">8. Wound dressing pads</h4> <p>This group of dressings include simple non‐adherent dressings, knitted viscose dressings (e.g. N/A Dressing ‐ Johnson &amp; Johnson), tulle and gauze dressings. They are usually in the form of woven cotton pads that are applied directly to the wound surface. They can be either non‐medicated (e.g. paraffin gauze dressing) or medicated (e.g. containing povidone iodine or chlorhexidine). </p> </section> </section> <section id="CD002106-sec-0040"> <h3 class="title" id="CD002106-sec-0040">Why it is important to do this review</h3> <p>Despite the increase in the types of dressings available, traditional dressings of paraffin‐impregnated gauze and absorbent cotton wool or gauze are still commonly used (<a href="./references#CD002106-bbs2-0066" title="HudspithS , RayattS . First aid and treatment of minor burns. BMJ2004;328(7454):1487‐9. ">Hudspith 2004</a>). The purpose of this review is to establish which type of dressing from the many now available is more effective in promoting healing and minimising discomfort and infection for patients with superficial and partial thickness burns. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD002106-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD002106-sec-0041"></div> <p>The objective of this review was to assess the effects of burn wound dressings for treating superficial and partial thickness burns. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD002106-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD002106-sec-0042"></div> <section id="CD002106-sec-0043"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD002106-sec-0044"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) that evaluated the effects of burn wound dressings used in the treatment of superficial and partial thickness burns. </p> </section> <section id="CD002106-sec-0045"> <h4 class="title">Types of participants</h4> <p>We focused on people of any age with a superficial or partial thickness burn determined by either clinical evaluation or objective assessment, or both, which required treatment in any health care setting. We did not include trials that recruited people with full thickness burns. </p> </section> <section id="CD002106-sec-0046"> <h4 class="title">Types of interventions</h4> <p>We included any wound dressing used singly and in combination to treat superficial and partial thickness burns. The groups of products considered included: </p> <p> <ul id="CD002106-list-0001"> <li> <p>hydrocolloid dressings;</p> </li> <li> <p>polyurethane film dressings;</p> </li> <li> <p>hydrogel dressings;</p> </li> <li> <p>silicon‐coated nylon dressings;</p> </li> <li> <p>biosynthetic skin substitute dressings;</p> </li> <li> <p>antimicrobial (silver and iodine containing) dressings;</p> </li> <li> <p>fibre dressings;</p> </li> <li> <p>wound dressing pads.</p> </li> </ul> </p> <p>We excluded topical skin agents, biological skin replacements and autologous cultured and non‐cultured skin engineering products, as these products tend to be used on people with deep dermal and full thickness burns, both of which were not within the remit of this review. We excluded trials which considered the treatment of hand burns. This decision was taken post hoc as it was felt that the treatment regime for these particular types of burns was different due to the anatomical site. </p> </section> <section id="CD002106-sec-0047"> <h4 class="title">Types of outcome measures</h4> <p>Studies were eligible for inclusion if they reported any of the following outcome measures: </p> <section id="CD002106-sec-0048"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD002106-list-0002"> <li> <p>Time to complete wound healing/proportion of burns completely healed in a specified time period. </p> </li> <li> <p>Change in wound surface area over time/proportion of wounds partly healed in a specified time period. </p> </li> </ol> </p> </section> <section id="CD002106-sec-0049"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD002106-list-0003"> <li> <p>Number of dressing changes.</p> </li> <li> <p>Cost of the dressings.</p> </li> <li> <p>Level of pain associated with the application and removal, or both, of the wound dressing.</p> </li> <li> <p>Patient perception, level of satisfaction with the application and removal of dressing.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Hospital length of stay (LOS).</p> </li> <li> <p>Need for surgery.</p> </li> <li> <p>Incidence of infection.</p> </li> <li> <p>Adverse events.</p> </li> </ol> </p> </section> </section> </section> <section id="CD002106-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD002106-sec-0051"> <h4 class="title">Electronic searches</h4> <p>For this first update we conducted searches of the following databases:</p> <p> <ul id="CD002106-list-0004"> <li> <p>The Cochrane Wounds Group Specialised Register (searched 8 November 2012);</p> </li> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2012, Issue 10); </p> </li> <li> <p>Ovid MEDLINE (2008 to October Week 4 2012);</p> </li> <li> <p>Ovid MEDLINE (In‐Process &amp; Other Non‐Indexed Citations, November 07, 2012);</p> </li> <li> <p>Ovid EMBASE (2008 to 2012 Week 44);</p> </li> <li> <p>EBSCO CINAHL (1982 to 2 November 2012).</p> </li> </ul> </p> <p>We used the following search strategy in the Cochrane Central Register of Controlled Trials (CENTRAL): </p> <p>#1 MeSH descriptor Bandages, Hydrocolloid explode all trees <br/> #2 hydrocolloid* or askina or biofilm or combiderm or comfeel or cutinova or duoderm or duoderm or (hydroactive NEXT gel*) or granuflex or hydrocoll or replicare or tegasorb or sureskin or hydrofibre or hydrofiber or aquacel <br/> #3 MeSH descriptor Alginates explode all trees <br/> #4 alginate NEXT dressing* <br/> #5 alginate* or calcium or algosteril or kaltostat or melgisorb or seasorb or sorbalgon or sorbsan or tegagen or “algisite M” <br/> #6 foam NEXT dressing* <br/> #7 allevyn or avance or biatain or cavi‐care or flexipore or lyofoam or spyrosorb or tielle or mepilex <br/> #8 MeSH descriptor Hydrogels explode all trees <br/> #9 hydrogel* or aquaform or debrisan or geliperm or granugel or hydrosorb or novogel or nu‐gel or "nu gel" or purilon or sterigel <br/> #10 film or films or arglaes or omiderm or polyurethane or tegaderm or opsite <br/> #11 MeSH descriptor Occlusive Dressings explode all trees <br/> #12 paraffin NEAR gauze <br/> #13 paranet or paratulle or unitulle or jelonet or bactigras or cuticerin or adaptic or atrauman <br/> #14 "retention tape" or hypafix or mefix or fixamul <br/> #15 biosynthetic NEAR substitute* <br/> #16 (biosynthetic NEAR dressing*) <br/> #17 transcyte or biobrane <br/> #18 (antimicrobial NEXT dressing*) or acticoat <br/> #19 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18) </p> <p>The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in <a href="./appendices#CD002106-sec-0180">Appendix 2</a>, <a href="./appendices#CD002106-sec-0181">Appendix 3</a> and <a href="./appendices#CD002106-sec-0182">Appendix 4</a> respectively. We combined the Ovid MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD002106-bbs2-0068" title="LefebvreC , ManheimerE , GlanvilleJ , on behalf of the Cochrane Information Retrieval Methods Group. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We combined the EMBASE and CINAHL searches with the trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<a href="./references#CD002106-bbs2-0071" title="Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random (accessed 8 April 2010). ">SIGN 2010</a>). We applied no date or language restrictions. </p> </section> <section id="CD002106-sec-0052"> <h4 class="title">Searching other resources</h4> <p>We handsearched the references of all identified studies and contacted authors for information about other published and unpublished studies. We contacted all dressing manufacturers to request information on trials evaluating dressings. </p> </section> </section> <section id="CD002106-sec-0053"> <h3 class="title" id="CD002106-sec-0053">Data collection and analysis</h3> <section id="CD002106-sec-0054"> <h4 class="title">Selection of studies</h4> <p>FC and JW scanned records retrieved by the initial search to exclude obviously irrelevant studies, and then three review authors (FC, HC and JW) screened titles and abstracts identified by the search against the inclusion criteria for the additional updates. Two review authors (FC and JW) retrieved and reviewed full‐text articles independently for the purpose of applying the inclusion criteria. In all instances, we resolved differences of opinion by discussion among the review authors. </p> </section> <section id="CD002106-sec-0055"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (FC and JW) extracted data from the studies independently, using standardised forms. The standardised forms allowed for the extraction of specific data such as type of care setting, key baseline variables of each group, e.g. depth of burn wound, size of burn wound, burn type, age, sex, description of the intervention and the control or co‐intervention including: secondary dressings used, frequency of dressings changes and length of treatment. We resolved all differences by discussion among the review authors. </p> </section> <section id="CD002106-sec-0056"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Risk of bias assessment was based on the method outlined in The Cochrane Collaboration's 'Risk of bias' tool (<a href="./references#CD002106-bbs2-0065" title="HigginsJPT , AltmanDG , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors). Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Two review authors (FC and JW) extracted data for risk of bias assessment and they are presented in a descriptive manner. We assessed the following characteristics: sequence generation; allocation concealment; blinding (of participants, personnel and outcome assessors); incomplete outcome data; selective outcome reporting; and other sources of bias. We categorised these judgements as low risk of bias, high risk of bias or 'unclear'. We resolved differences of opinion by discussion among the review authors. </p> </section> <section id="CD002106-sec-0057"> <h4 class="title">Data synthesis</h4> <p>For proportions (dichotomous outcomes, e.g. percentage of burns healed), we used risk ratios (RR). We calculated the mean difference (MD) for continuous data and pooled data in a meta‐analysis. </p> <p>We made all analyses on an intention‐to‐treat basis, where possible, and where not possible this was clearly stated. Time to wound healing was to be analysed as survival (time‐to‐event) outcomes if possible, using the appropriate analytical method (as per the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> version 5.0)(<a href="./references#CD002106-bbs2-0060" title="DeeksJJ , HigginsJPT , AltmanDG , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors). Chapter 9:  Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> <p>We gave consideration to the appropriateness of pooling and meta‐analysis. Two review authors extracted and summarised data from all eligible studies independently using a standard data extraction tool. </p> </section> <section id="CD002106-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We used a fixed‐effect model where there was no evidence of significant heterogeneity between studies (I<sup>2</sup> statistic less than 40%), and employed a random‐effects model when heterogeneity was likely (I<sup>2</sup> statistic more than 40%) (<a href="./references#CD002106-bbs2-0062" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>; <a href="./references#CD002106-bbs2-0064" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). </p> <p>We gave consideration to the appropriateness of subgroup analyses based on the type of burn injury, i.e. superficial or deep partial thickness burn, but many of the studies did not report on the extent of burn depth. If they did, subgroup analysis was to be done by calculation of RR or mean difference (MD) in each subgroup with examination of the 95% confidence intervals (95% CI). We would take non‐overlap in intervals to indicate a statistically significant difference between subgroups. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD002106-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD002106-sec-0059"></div> <section id="CD002106-sec-0060"> <h3 class="title">Description of studies</h3> <p>From independent scrutiny of the titles and abstracts from all the searches conducted to date, a total of 30 studies met the inclusion criteria (see <a href="./references#CD002106-sec-0192" title="">Characteristics of included studies</a>). Twenty‐one trials did not meet the inclusion criteria and we excluded them from the review; the reasons for exclusion are detailed in the <a href="./references#CD002106-sec-0193" title="">Characteristics of excluded studies</a>. Seven studies are classified as 'awaiting assessment' (<a href="./references#CD002106-bbs2-0052" title="MabroukA , BoughdadiNS , HelalHA , ZakiBM , MaherA . Moist occlusive dressing (Aquacel Ag) versus moist open dressing (MEBO) in the management of partial‐thickness facial burns: a comparative study in Ain Shams University. Burns2012;38(3):396‐403. ">Mabrouk 2012</a>; <a href="./references#CD002106-bbs2-0053" title="MostaqueAK , RahmanKBMA . Comparisons of the effects of biological membrane (amnion) and silver sulfadiazine in the management of burn wounds in children. Journal of Burn Care and Research 2011;32(2):200‐209. ">Mostaque 2011</a>; <a href="./references#CD002106-bbs2-0054" title="OstlieDJ , JuangD ,   Aguayo P , Pettiford‐CunninghamJP , ErkmannEA , RashDE , et al. Topical silver sulfadiazine vs collagenase ointment for the treatment of partial thickness burns in children: A prospective randomized trial. Journal of Pediatric Surgery 2012;47(6):1204‐1207. ">Ostlie 2012</a>; <a href="./references#CD002106-bbs2-0055" title="PiatkowskiA , DrummerN , AndriessenA , UlrichD , PalluaN . Randomized controlled single center study comparing a polyhexanide containing bio‐cellulose dressing with silver sulfadiazine cream in partial‐thickness dermal burns. Burns2011;37(5):799‐803. Piatkowski De GrzymalaA , DrummerN , AndriessenA , UlrichD , PalluaN . RCT comparing a polihexanide containing bio‐cellulose dressing with silver sulfadiazine cream in partial thickness dermal burns. EWMA Journal 2011;11(2 Suppl):63. ">Piatkowski 2011</a>; <a href="./references#CD002106-bbs2-0056" title="SilversteinP , HeimbachD , MeitesH , LatenserB , MozingoD , MullinsF , et al. An open, parallel, randomized, comparative, multicenter study to evaluate the cost‐effectiveness, performance, tolerance, and safety of a silver‐containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream. Journal of Burn Care and Research 2011;32(6):617‐26. SilversteinP , HeimbachD , MeitesH , LatenserB , MozingoD , MullinsF , et al. Soft silicone dressing with silver versus silver sulfadiazine cream in the treatment of partial‐thickness burns: a randomised controlled trial. EWMA Journal2010;10(2):149, Abstract P84. ">Silverstein 2011</a>; <a href="./references#CD002106-bbs2-0057" title="VerbelenJ , HoeksemaH , HeynemanA , PirayeshA , MonstreyS . Aquacel Ag versus Acticoat: Intermediate results of a prospective, randomized, controlled mono centre study in 100 patients. Burns2011;37:S8. ">Verbelen 2011</a>; <a href="./references#CD002106-bbs2-0058" title="ZhouP‐Y , XiaZ‐F , BenD‐F , MaB , FangH , FengP . Clinical application of Aquacel‐Ag dressing in treatment of pediatric superficial I burn wounds. Academic Journal of Second Military Medical University 2011;32(12):1321‐3. ">Zhou 2011</a>). </p> <section id="CD002106-sec-0061"> <h4 class="title">1. Hydrocolloid dressings</h4> <p>Five studies with 442 participants compared hydrocolloid dressings with other conventional burn wound dressings (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>; <a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>; <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>; <a href="./references#CD002106-bbs2-0030" title="WyattD , McGowanD , NajarianMP . Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second‐degree burns. Journal of Trauma1990;30(7):857‐65. ">Wyatt 1990</a>). The studies were published between 1984 and 1995 and carried out in Canada (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>), the United Kingdom (<a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>; <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>) and the United States (<a href="./references#CD002106-bbs2-0030" title="WyattD , McGowanD , NajarianMP . Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second‐degree burns. Journal of Trauma1990;30(7):857‐65. ">Wyatt 1990</a>). Studies took place in emergency departments, outpatient clinics or tertiary burn care centres. The type of burn injury was generally limited to partial thickness burns. The definition of superficial or partial thickness burns was described in only one study (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>). The inclusion and exclusion criteria did not differ considerably between the studies. Within the studies, patients were generally well matched for sex, age, location and size of burn injury. </p> <p>The traditional treatments which acted as controls included chlorhexidine‐impregnated tulle‐gras in three of the trials (<a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>; <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>) and silver sulphadiazine (SSD) in two trials (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>; <a href="./references#CD002106-bbs2-0030" title="WyattD , McGowanD , NajarianMP . Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second‐degree burns. Journal of Trauma1990;30(7):857‐65. ">Wyatt 1990</a>). The time for changing the comparator dressings differed in the trials, ranging from twice daily to every three to five days to when required. The number of dressing changes or ease of dressing change was reported in four studies (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>; <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>; <a href="./references#CD002106-bbs2-0030" title="WyattD , McGowanD , NajarianMP . Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second‐degree burns. Journal of Trauma1990;30(7):857‐65. ">Wyatt 1990</a>). The hydrocolloid dressings were changed every five days or when required in trials where this was reported. </p> </section> <section id="CD002106-sec-0062"> <h4 class="title">2. Polyurethane film dressings</h4> <p>Two trials with 106 patients compared polyurethane film dressings with conventional burn wound therapy (<a href="./references#CD002106-bbs2-0022" title="NealD , WhalleyP , FlowersM , WilsonD . The effects of an adherent polyurethane film and conventional absorbent dressing in patients with small partial thickness burns. British Journal of Clinical Practice1981;35(7‐8):254‐7. ">Neal 1981</a>; <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>). The studies were carried out in an outpatient clinic of an accident and emergency department. The type of burn injury examined was limited to partial thickness burns although its definition was described in only one study (<a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>). The mechanism of burn injury was described in both studies (<a href="./references#CD002106-bbs2-0022" title="NealD , WhalleyP , FlowersM , WilsonD . The effects of an adherent polyurethane film and conventional absorbent dressing in patients with small partial thickness burns. British Journal of Clinical Practice1981;35(7‐8):254‐7. ">Neal 1981</a>; <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>). The inclusion and exclusion criteria did not differ considerably amongst the two studies. Within the studies, patients were generally well matched for sex, age, location and size of burn injury. </p> <p>The conventional (control) dressing varied slightly between the studies and included chlorhexidine‐impregnated gauze (<a href="./references#CD002106-bbs2-0022" title="NealD , WhalleyP , FlowersM , WilsonD . The effects of an adherent polyurethane film and conventional absorbent dressing in patients with small partial thickness burns. British Journal of Clinical Practice1981;35(7‐8):254‐7. ">Neal 1981</a>) and paraffin‐impregnated gauze (<a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>). The polyurethane film dressing was changed only if leakage, infection or an adverse skin reaction occurred (<a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>). The control dressings were changed on day six post‐burn in the <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a> study. The control or conventional dressings in the <a href="./references#CD002106-bbs2-0022" title="NealD , WhalleyP , FlowersM , WilsonD . The effects of an adherent polyurethane film and conventional absorbent dressing in patients with small partial thickness burns. British Journal of Clinical Practice1981;35(7‐8):254‐7. ">Neal 1981</a> study were not changed until the third or fifth day post‐burn. </p> </section> <section id="CD002106-sec-0063"> <h4 class="title">3. Hydrogel dressings</h4> <p>Three studies with 235 patients compared hydrogel dressings with SSD or paraffin gauze with or without topical antibiotics for a partial thickness burn injury (<a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a>; <a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a>; <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a>). In <a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a> and <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a>, each patient acted as his or her own control; a total of 310 wound sites with similar depth and surface area, contiguous or anatomically separated, were evaluated with the following measures: healing time expressed in days, assessment of pain, quality of healing, sensitivity of the scar and frequency of dressing changes. The endpoint of healing was defined as the complete epithelialisation of the wound. Examinations were performed on days 0, 2, 4 and 8 and on the day of complete healing in both studies. The studies were undertaken in burn centres in Europe (<a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a>; <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a>). <a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a> evaluated time to wound healing at 6, 9, 12, 15, 18 and 21 days, wound infection, pain and adverse effects. </p> </section> <section id="CD002106-sec-0064"> <h4 class="title">4. Silicon‐coated nylon dressings</h4> <p>Two studies (<a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a>; <a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a>) compared the effectiveness of silicon‐coated nylon dressings with SSD in 142 children presenting within 24 hours of injury with a partial thickness burn. A secondary dressing was applied over the silicon‐coated nylon dressing which consisted of a gauze dressing soaked with chlorhexidine in one study (<a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a>) and wet and dry cotton gauze in the second study (<a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a>). </p> <p>Outcome measures assessed by <a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a> included depth of the burn, the number of cumulative dressings, presence or absence of complete epithelial cover, and number of reported cases of infection and bleeding. The criterion used to define the complete epithelial cover time was the time when a full surface shining layer of epithelial cells was observed. Evaluation of the burn was made between day three and six after injury. In <a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a>, trained burn specialist nurses assessed the following outcome measures: wound healing, eschar formation, pain at dressing with the use of an objective pain scale tool and the time required for dressing changes. </p> </section> <section id="CD002106-sec-0065"> <h4 class="title">5. Biosynthetic skin substitute dressings</h4> <p>Ten studies compared the effectiveness of biosynthetic dressings with twice‐daily application of SSD or other comparators in 434 patients. Five studies used Biobrane (Smith &amp; Nephew) (<a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a>; <a href="./references#CD002106-bbs2-0005" title="CassidyC , StPeterSD , LaceyS , BeeyM , Ward‐SmithP , SharpRJ , et al. Biobrane versus Duoderm for the treatment of intermediate thickness burns in children: a prospective randomized trial. Burns2005;31(7):890‐3. ">Cassidy 2005</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a>), three used Hydron (Abbott Laboratories) (<a href="./references#CD002106-bbs2-0007" title="CurreriPW , DesaiM , BartlettR , HeimbachD , ParshleyP , TrunkeyD . Safety and efficacy of a new synthetic burn dressing: a multicenter study. Archives of Surgery1980;115(8):925‐7. ">Curreri 1980</a>; <a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a>; <a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a>) and one study used TransCyte (Smith &amp; Nephew) (<a href="./references#CD002106-bbs2-0023" title="NoordenbosJ , DoreC , HansbroughJF . Safety and efficacy of TransCyte for the treatment of partial‐thickness burns. Journal of Burn Care and Rehabilitation1999;20(4):275‐81. ">Noordenbos 1999</a>). An additional study by <a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a> had a three arm design in which patients were randomised to receive either Biobrane or TransCyte or SSD. A total of four studies (<a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a>) had patients serve as their own controls and similar areas of burns were randomised to receive either the intervention or control dressing. </p> <p>The inclusion and exclusion criteria did not differ considerably between the 10 studies. Within the studies, patients were generally well matched for sex, age and location, although size of burn injury could vary. Outcome measures were similar across the studies with emphasis placed on healing times, infection rates, cost of dressings, levels of pain and length of stay in hospital. </p> </section> <section id="CD002106-sec-0066"> <h4 class="title">6. Antimicrobial (silver and iodine‐containing) dressings</h4> <p>Five studies compared the efficacy of silver‐impregnated dressing (Acticoat, Smith and Nephew) with SSD on pain levels during dressing changes in 331 patients with partial thickness burns (<a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a>; <a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a>; <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>; <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a>; <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>). The study by <a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a> reported on 166 wound sites rather than number of patients. The studies were carried out in tertiary burn centres with patients serving as their own controls (<a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>) or randomised to SSD (<a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a>; <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>; <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a>) or SSD powder (<a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a>). The outcome of interest (pain scores as assessed and reported using the visual analogue pain scale score) were collected during the initial application of the dressing (<a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>) and once during the dressing change for <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a> and <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>. Other outcomes of interest for <a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a> and <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a> included healing time expressed in number of days, and for <a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a> number of people healed. </p> </section> <section id="CD002106-sec-0067"> <h4 class="title">7. Fibre dressings</h4> <p>Three studies evaluated the efficacy and safety of fibre‐type dressings. In the first study by <a href="./references#CD002106-bbs2-0006" title="CostagliolaM , CastedeJC , ChaouatM , MimounM , PannierM , Pellerin Petal . Algosteril dressing (calcium alginate) versus Flammazine (silver sulphadiazine) in the treatment of second‐degree burns. Fourth Australian Wound Management Association Conference. 2002:53. ">Costagliola 2002</a>, calcium alginate was compared with SSD in the treatment of 59 patients with 73 partial thickness burns. In <a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a> and <a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a> hydrofibre dressings were compared with SSD in 154 patients. With burn characteristics similar in all groups, all patients in the <a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a> study were observed for a maximum of three weeks until the wound had completely healed. Outcomes measures of interest included length of time to onset of healing, pain, amount of care and treatment safety required and evaluated on a weekly basis. Cost outcomes were also measured by <a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a>, including total dressing cost, total hospital cost and transport cost. </p> <section id="CD002106-sec-0068"> <h5 class="title">Patient baseline characteristics</h5> <p>Most studies enrolled patients with a partial thickness burn. The definition of a partial thickness burn injury was absent in most studies with only <a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>, <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>, <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a> and <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a> providing the reader with a definition of a burn wound. <a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a> defined burn depth according to an unusual nomenclature, i.e. three levels, four categories method and the size of the burn according to the nine categories method. <a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a> matched burn depth estimates with laser Doppler specific criteria. The percentage of total burn surface area (%TBSA) and specific inclusion and exclusion criteria was reported in all studies except for <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>. All trials had clear inclusion and exclusion criteria and there was some consistency between studies. Within the studies, patients were generally well matched for sex, age and size of burn injury. </p> </section> </section> </section> <section id="CD002106-sec-0069"> <h3 class="title">Risk of bias in included studies</h3> <p>Details of the quality assessment based on the method outlined in <a href="./references#CD002106-bbs2-0065" title="HigginsJPT , AltmanDG , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors). Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a> are given in the table '<a href="./references#CD002106-sec-0192" title="">Characteristics of included studies</a>', <a href="#CD002106-fig-0001">Figure 1</a> and <a href="#CD002106-fig-0002">Figure 2</a>. Additionally, a brief descriptive analyses of the studies is provided below. In general, we assessed study quality as poor to very poor. The trials included had serious methodological or reporting shortcomings or both. </p> <div class="figure" id="CD002106-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002106-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD002106-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002106-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD002106-sec-0070"> <h4 class="title">Allocation</h4> <section id="CD002106-sec-0071"> <h5 class="title">Randomisation and adequacy of allocation concealment</h5> <p>The method of randomisation was adequate in only 11 of the 30 studies (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>; <a href="./references#CD002106-bbs2-0007" title="CurreriPW , DesaiM , BartlettR , HeimbachD , ParshleyP , TrunkeyD . Safety and efficacy of a new synthetic burn dressing: a multicenter study. Archives of Surgery1980;115(8):925‐7. ">Curreri 1980</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a>; <a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a>; <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a>; <a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a>; <a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a>; <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>; <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>). Six trials used matched controls by randomising paired wounds to treatment by opposite modalities (<a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a>; <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a>; <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>). <a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a> and <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a> had patients serve as their own controls. Allocation concealment was adequately documented and described in only four studies (<a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>; <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>). </p> </section> </section> <section id="CD002106-sec-0072"> <h4 class="title">Blinding</h4> <p>Only two trials used blinded outcome assessors to measure an overall impression of healing (<a href="./references#CD002106-bbs2-0030" title="WyattD , McGowanD , NajarianMP . Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second‐degree burns. Journal of Trauma1990;30(7):857‐65. ">Wyatt 1990</a>) and wound evaluation (<a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a>). </p> </section> <section id="CD002106-sec-0073"> <h4 class="title">Incomplete outcome data</h4> <p>Seventeen studies detail patients lost to follow‐up (<a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a>; <a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a>; <a href="./references#CD002106-bbs2-0005" title="CassidyC , StPeterSD , LaceyS , BeeyM , Ward‐SmithP , SharpRJ , et al. Biobrane versus Duoderm for the treatment of intermediate thickness burns in children: a prospective randomized trial. Burns2005;31(7):890‐3. ">Cassidy 2005</a>; <a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a>; <a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a>; <a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a>; <a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a>; <a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a>; <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>; <a href="./references#CD002106-bbs2-0022" title="NealD , WhalleyP , FlowersM , WilsonD . The effects of an adherent polyurethane film and conventional absorbent dressing in patients with small partial thickness burns. British Journal of Clinical Practice1981;35(7‐8):254‐7. ">Neal 1981</a>; <a href="./references#CD002106-bbs2-0023" title="NoordenbosJ , DoreC , HansbroughJF . Safety and efficacy of TransCyte for the treatment of partial‐thickness burns. Journal of Burn Care and Rehabilitation1999;20(4):275‐81. ">Noordenbos 1999</a>; <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a>; <a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>; <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>). None of the studies were analysed by intention‐to‐treat. </p> </section> <section id="CD002106-sec-0074"> <h4 class="title">Selective reporting</h4> <p>Seventeen studies were free from obvious selective reporting (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>; <a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a>; <a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a>; <a href="./references#CD002106-bbs2-0005" title="CassidyC , StPeterSD , LaceyS , BeeyM , Ward‐SmithP , SharpRJ , et al. Biobrane versus Duoderm for the treatment of intermediate thickness burns in children: a prospective randomized trial. Burns2005;31(7):890‐3. ">Cassidy 2005</a>; <a href="./references#CD002106-bbs2-0006" title="CostagliolaM , CastedeJC , ChaouatM , MimounM , PannierM , Pellerin Petal . Algosteril dressing (calcium alginate) versus Flammazine (silver sulphadiazine) in the treatment of second‐degree burns. Fourth Australian Wound Management Association Conference. 2002:53. ">Costagliola 2002</a>; <a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a>; <a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a>; <a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a>; <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>; <a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a>; <a href="./references#CD002106-bbs2-0023" title="NoordenbosJ , DoreC , HansbroughJF . Safety and efficacy of TransCyte for the treatment of partial‐thickness burns. Journal of Burn Care and Rehabilitation1999;20(4):275‐81. ">Noordenbos 1999</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>; <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>; <a href="./references#CD002106-bbs2-0030" title="WyattD , McGowanD , NajarianMP . Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second‐degree burns. Journal of Trauma1990;30(7):857‐65. ">Wyatt 1990</a>). </p> </section> <section id="CD002106-sec-0075"> <h4 class="title">Other potential sources of bias</h4> <p>Eleven studies were free from other obvious sources of potential bias (<a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a>; <a href="./references#CD002106-bbs2-0007" title="CurreriPW , DesaiM , BartlettR , HeimbachD , ParshleyP , TrunkeyD . Safety and efficacy of a new synthetic burn dressing: a multicenter study. Archives of Surgery1980;115(8):925‐7. ">Curreri 1980</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a>; <a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a>; <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>; <a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a>; <a href="./references#CD002106-bbs2-0022" title="NealD , WhalleyP , FlowersM , WilsonD . The effects of an adherent polyurethane film and conventional absorbent dressing in patients with small partial thickness burns. British Journal of Clinical Practice1981;35(7‐8):254‐7. ">Neal 1981</a>; <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a>; <a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>; <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>). </p> </section> </section> <section id="CD002106-sec-0076"> <h3 class="title" id="CD002106-sec-0076">Effects of interventions</h3> <p>Results are presented for each dressing comparison and primary and secondary outcomes are presented when reported. Although the trials included a number of similar outcomes, sometimes the heterogeneous nature of the studies (i.e. use of different comparators), the absence of data, poor reporting or variations in reporting precluded formal statistical analysis. In most instances, we synthesised the results in a narrative review. Where studies analysed time‐to‐event data using methods for continuous outcomes (e.g. time to healing as "mean healing time") we present the results narratively and did not pool studies. The most appropriate way of summarising time‐to‐event data such as time to healing is by survival analysis with the hazard ratio as the measure of effect. It is not appropriate to analyse time to healing as continuous data since the relevant times are only known for the subset of participants who experienced the (healing) event. Censored participants cannot be included in such analyses, which almost certainly will introduce bias (<a href="./references#CD002106-bbs2-0065" title="HigginsJPT , AltmanDG , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors). Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <section id="CD002106-sec-0077"> <h4 class="title">1. Hydrocolloid dressings</h4> <p>A total of five trials comparing hydrocolloid dressings with other dressing types or with different hydrocolloid dressings were included in this review. </p> <section id="CD002106-sec-0078"> <h5 class="title">a. Hydrocolloid dressings compared with chlorhexidine‐impregnated paraffin gauze dressing (three trials, 344 people) </h5> <section id="CD002106-sec-0079"> <h6 class="title">Time to complete wound healing</h6> <p>We found three randomised controlled trials (RCTs) which compared hydrocolloid dressings with chlorhexidine‐impregnated paraffin gauze dressings (<a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>; <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>). None of the trials found a significant difference in healing rates. The trials could not be pooled as no variance data were reported. </p> <p><a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a> found no significant difference in time to wound healing (median wound healing time: 12 days in each group; P = 0.89). </p> <p><a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a> had three study arms; hydrocolloid dressing, hydrocolloid dressing plus silver sulphadiazine (SSD) and chlorhexidine‐impregnated paraffin gauze dressing. There was no significant difference in mean time to wound healing between hydrocolloid dressing and chlorhexidine‐impregnated paraffin gauze dressing (10.6 days with hydrocolloid versus 11.1 days with chlorhexidine‐impregnated paraffin gauze; P value reported as not significant). No variance data were reported in the study. </p> <p><a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a> reported that there was no statistically significant difference between the total mean time to wound healing between hydrocolloid dressing and chlorhexidine‐impregnated paraffin gauze dressing (14.18 days with hydrocolloid versus 11.83 days with chlorhexidine‐impregnated paraffin gauze; P value reported as not significant). No variance data were reported in the study. </p> </section> <section id="CD002106-sec-0080"> <h6 class="title">Patient perception/level of satisfaction</h6> <p>In the study by <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>, investigators and participants rated the hydrocolloid dressing more highly than the chlorhexidine‐impregnated paraffin gauze (10‐item visual analogue scale (VAS), with 0 = useless and 10 = excellent: participants' rating: 9.04 with hydrocolloid versus 6.86 with chlorhexidine‐impregnated paraffin gauze; P &lt; 0.02; investigators' rating: 9.31 with hydrocolloid versus 6.9 with chlorhexidine‐impregnated paraffin gauze; P = 0.005); the study does not report if these ratings were mean values. The study does not report that the raters were blinded therefore bias cannot be ruled out. </p> </section> <section id="CD002106-sec-0081"> <h6 class="title">Level of pain</h6> <p><a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a> found no significant difference between treatments in background pain, pain associated with dressing changes (pain rated using a visual analogue scale), or ease of dressing removal (background pain: mean scores not reported; P = 0.28; pain on dressing change: mean scores not reported; P = 0.96; ease of dressing removal: mean scores not reported; P = 0.49). </p> <p>Similarly, <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a> recorded pain using a visual analogue score of zero to 10 (zero = no pain and 10 = severe pain) by the clinician and by the patient (where possible). No significant difference between the pain scores of patients was reported (mean scores not reported; P = 0.82). During the clinical assessment, however, patients receiving the chlorhexidine‐impregnated paraffin gauze dressing sometimes complained that the dressing would stick to the wound surface, causing pain. Patients in the hydrocolloid group complained of pain when the adhesive border was removed from surrounding unshaved area (numerical or graphical results not presented). </p> <p>Pain as an outcome measures was not reported by <a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>. </p> </section> <section id="CD002106-sec-0082"> <h6 class="title">Number of dressing changes</h6> <p>Only two of the three trials reported the frequency of dressing changes. In the <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a> study, dressings were changed more often because of leakage in the hydrocolloid group compared with the chlorhexidine‐impregnated paraffin gauze group (15/94 (15%) with hydrocolloid versus 3/89 (3%) with chlorhexidine‐impregnated paraffin gauze dressing; P &lt; 0.02). This difference was statistically significant. </p> <p>In contrast <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a> reported significantly fewer dressing changes per patient during treatment with hydrocolloid dressing compared with chlorhexidine‐impregnated paraffin gauze dressing (2.3 with hydrocolloid dressing versus 4.1 with chlorhexidine‐impregnated paraffin gauze dressing; P &lt; 0.0001; reasons for dressing changes were not reported and no variance data were reported in the study). Dressing changes were not reported by <a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>. </p> </section> <section id="CD002106-sec-0083"> <h6 class="title">Adverse events</h6> <p>In the study by <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>, pain was reported in one person and rash in two people with hydrocolloid dressing. </p> </section> <section id="CD002106-sec-0084"> <h6 class="title">Incidence of infection</h6> <p><a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a> reported that one person in the hydrocolloid group withdrew from the study because of infection, but did not report any cases of infection in those who remained in the study (<a href="./references#CD002106-fig-0003" title="">Analysis 1.1</a>) and this was not significant. <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a> reported no significant difference in increase in pathogenic bacterial isolates between the hydrocolloid dressing and the chlorhexidine‐impregnated paraffin gauze dressing (P = 0.12). In <a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a> no significant difference in pathogenic bacterial isolates between hydrocolloid dressing and the chlorhexidine‐impregnated paraffin gauze dressing was noted (P = 0.02), although the organism most commonly acquired in both groups was <i>Staphylococcus aureus</i>. </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, quality of life, length of stay and need for surgery were not addressed by any of these studies. </p> </section> <section id="CD002106-sec-0085"> <h6 class="title">Summary</h6> <p>Overall there is no evidence of a difference between hydrocolloid dressings and chlorhexidine‐impregnated paraffin gauze, although the evidence is of poor quality. </p> </section> </section> <section id="CD002106-sec-0086"> <h5 class="title">b. Hydrocolloid dressings compared with chlorhexidine‐impregnated paraffin gauze dressing plus silver sulphadiazine (SSD) cream (one trial, 48 people) </h5> <section id="CD002106-sec-0087"> <h6 class="title">Time to complete wound healing</h6> <p>One study by <a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a> compared hydrocolloid dressings with chlorhexidine‐impregnated paraffin gauze plus SSD after initial burn in 48 adults with partial thickness burns. They found no statistically significant difference between treatments for the time to wound healing (time to wound healing in the hydrocolloid group: 10.7 days (4.8), paraffin gauze group:11.2 days (4.2) P = 0.76), however 18 out of 48 participants were lost to follow‐up (nine from each group) and this may have introduced bias. </p> </section> <section id="CD002106-sec-0088"> <h6 class="title">Number of dressing changes</h6> <p>Dressings were changed less frequently with hydrocolloid dressing compared with chlorhexidine‐impregnated paraffin gauze plus SSD (mean number of dressing changes: three with hydrocolloid dressing, eight with chlorhexidine‐impregnated paraffin gauze plus SSD; P &lt; 0.02). Although reasons for dressing changes were not given, this result was to be expected, as chlorhexidine‐impregnated paraffin gauze plus SSD dressings were changed routinely, whereas hydrocolloid dressings were only changed when there was an indication of leakage or suspected infection. </p> </section> <section id="CD002106-sec-0089"> <h6 class="title">Level of pain</h6> <p>There was no significant difference between treatment groups for pain. <a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a> reported median pain score baseline: 3/10 in the hydrocolloid group, 2/10 in the chlorhexidine‐impregnated paraffin gauze plus SSD group; this was reported as non‐significant; the variance data and the P value were not reported. The median pain score at second visit: 0/10 with hydrocolloid compared with 1/10 with chlorhexidine‐impregnated paraffin gauze plus SSD; reported as non‐significant; the variance data and P value were not reported. </p> </section> <section id="CD002106-sec-0090"> <h6 class="title">Patient perception, level of satisfaction with the application and removal of dressing</h6> <p><a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a> reported that application and removal were more frequently rated as "easy" with hydrocolloid dressing compared with chlorhexidine‐impregnated paraffin gauze plus silver sulphadiazine. </p> </section> <section id="CD002106-sec-0091"> <h6 class="title">Adverse events</h6> <p><a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a> did not report any wound infections. However, three people who developed cellulitis during treatment were excluded from the RCT. </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, quality of life, length of hospital stay and need for surgery were not addressed by this study. </p> </section> <section id="CD002106-sec-0092"> <h6 class="title">Summary</h6> <p>Overall we found no evidence of a difference between hydrocolloid dressing and chlorhexidine‐impregnated paraffin gauze dressing plus SSD cream, although there is only poor quality evidence. </p> </section> </section> <section id="CD002106-sec-0093"> <h5 class="title">c. Hydrocolloid dressing compared with silver sulphadiazine cream (one trial, 50 people)</h5> <section id="CD002106-sec-0094"> <h6 class="title">Time to complete wound healing</h6> <p>We found one study (<a href="./references#CD002106-bbs2-0030" title="WyattD , McGowanD , NajarianMP . Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second‐degree burns. Journal of Trauma1990;30(7):857‐65. ">Wyatt 1990</a>) which compared hydrocolloid dressings with sterile gauze plus SSD after initial burn cleaning. Hydrocolloid dressing significantly reduced mean healing time when compared with SSD. Hydrocolloid dressing (10.23 days +/‐ 3.19) versus SSD (15.59 days +/‐ 8.32) (P &lt; 0.01). Wyatt also found that after complete wound healing, wound appearance, re‐pigmentation and overall investigator/participant satisfaction were significantly better with the hydrocolloid dressing compared with SSD (wound appearance: P &lt; 0.01; re‐pigmentation: P &lt; 0.01; investigator/participant satisfaction: P &lt; 0.001). An assessor, blind to treatment allocation, rated overall wound healing and reported that 64% of wounds in the hydrocolloid group appeared healthy and well hydrated compared with 35% of wounds in the SSD group. </p> </section> <section id="CD002106-sec-0095"> <h6 class="title">Number of dressing changes</h6> <p>There were significantly fewer dressing changes with the hydrocolloid dressing compared with SSD (mean number of dressing changes: 3.55 with hydrocolloid dressing versus 22.2 with SSD; mean difference (MD) ‐18.65 95% confidence interval (CI) ‐22.54 to ‐14.76; P &lt; 0.00001) (<a href="./references#CD002106-fig-0004" title="">Analysis 2.1</a>). The number of minutes taken to change the dressing was 4.82 minutes with hydrocolloid versus 9.05 minutes with SSD; P &lt; 001). However, this result was to be expected, as SSD dressings were changed routinely, whereas there was no indication to change the hydrocolloid dressings without leakage or suspected infection. </p> </section> <section id="CD002106-sec-0096"> <h6 class="title">Level of pain</h6> <p>Patients graded pain on a scale of 0 to 10 (0 = no pain, 10 = maximum pain). Pain was significantly more severe in the those treated with SSD than those treated with a hydrocolloid dressing (mean pain score 2.28 for those in the SSD group versus 1.09 for those treated with a hydrocolloid dressing; MD ‐1.19 95%CI ‐1.82 to ‐0.56; P &lt; 0.00002) (<a href="./references#CD002106-fig-0005" title="">Analysis 2.2</a>). </p> </section> <section id="CD002106-sec-0097"> <h6 class="title">Patient perception, level of satisfaction with the application and removal of dressing</h6> <p>Dressing application and removal were rated as easier, and dressing comfort as better with hydrocolloid dressing compared with SSD (P &lt; 0.01). </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, quality of life, length of hospital stay, adverse events and need for surgery were not addressed by this study. </p> </section> <section id="CD002106-sec-0098"> <h6 class="title">Summary</h6> <p>Overall we found that hydrocolloid dressings may heal burns more quickly than SSD cream, although this evidence is low quality. </p> </section> </section> </section> <section id="CD002106-sec-0099"> <h4 class="title">2. Polyurethane film dressing</h4> <p>A total of two trials compared polyurethane film dressings with alternatives.</p> <section id="CD002106-sec-0100"> <h5 class="title">a. Polyurethane film dressing compared with paraffin gauze dressing (one trial, 55 people) </h5> <p>We found one study by <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>, which compared polyurethane film with paraffin gauze dressing. </p> <section id="CD002106-sec-0101"> <h6 class="title">Time to complete wound healing</h6> <p>The study reported that no significant difference was found between polyurethane film and the paraffin‐impregnated gauze in time to wound healing (median days to wound healing: seven days (range six to 30 days) with paraffin gauze compared with 10 days (range five to 24 days) with polyurethane film; P &gt; 0.05). </p> </section> <section id="CD002106-sec-0102"> <h6 class="title">Patient perception, level of satisfaction with the application and removal of dressing</h6> <p>The same study reported no significant difference between groups in participant satisfaction (satisfaction ratings were self assessed or, in the case of children, assessed by their parents; proportion of people "satisfied": 27/29 (96%) with polyurethane film versus 20/25 (80%) with paraffin gauze; reported as not significant; P value not reported). </p> </section> <section id="CD002106-sec-0103"> <h6 class="title">Level of pain</h6> <p>Patients were assessed for pain on a four‐item scale for degrees of no pain, mild, moderate and severe pain. A total of 3/30 (10%) patients with polyurethane film compared with 4/24 (16%) with paraffin gauze reported moderate to severe pain; differences reported as not significant; P value not reported. </p> </section> <section id="CD002106-sec-0104"> <h6 class="title">Incidence of infection</h6> <p>There was no difference in rates of wound infection, 3/30 (10%) people in the polyurethane group and 2/25 (8%) people in the paraffin gauze group (risk ratio (RR) 1.25, 95% CI 0.23 to 6.90; P = 0.80) (<a href="./references#CD002106-fig-0006" title="">Analysis 3.1</a>). No infection required antibiotic treatment. </p> </section> <section id="CD002106-sec-0105"> <h6 class="title">Adverse events</h6> <p><a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a> reported skin reactions such as follicular exanthema and itching in 2/30 (7%) people with polyurethane film (data for control group not reported). </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, number of dressing changes, quality of life, length of hospital stay, adverse events and need for surgery were not addressed by this study. </p> </section> <section id="CD002106-sec-0106"> <h6 class="title">Summary</h6> <p>Overall we found no evidence of a difference between polyurethane film and paraffin gauze dressing, although there is only poor quality evidence. </p> </section> </section> <section id="CD002106-sec-0107"> <h5 class="title">b. Polyurethane film dressing compared with chlorhexidine‐impregnated paraffin gauze dressing (one trial, 51 people) </h5> <section id="CD002106-sec-0108"> <h6 class="title">Time to complete wound healing</h6> <p>We found one study by <a href="./references#CD002106-bbs2-0022" title="NealD , WhalleyP , FlowersM , WilsonD . The effects of an adherent polyurethane film and conventional absorbent dressing in patients with small partial thickness burns. British Journal of Clinical Practice1981;35(7‐8):254‐7. ">Neal 1981</a> which compared polyurethane film with chlorhexidine‐impregnated paraffin gauze dressing. The author found polyurethane film significantly reduced healing time compared with chlorhexidine‐impregnated paraffin gauze (mean healing time: 10.0 days (standard deviation (SD) 5.00) with polyurethane film, 14.1 days (SD 7.00) with chlorhexidine‐impregnated paraffin gauze; P = 0.02). The RCT found that at 10 days after injury, polyurethane film significantly increased healing compared with chlorhexidine‐impregnated paraffin gauze (results presented graphically; P &lt; 0.05). However, more than 10 days after injury, there was no significant difference in wound healing between the two treatment groups (results presented graphically; P value not given but study author reported as not significant). </p> </section> <section id="CD002106-sec-0109"> <h6 class="title">Level of pain</h6> <p>Less pain (by comparative ranking on a "pain" perception diagram assessing intensity and duration) was experienced with polyurethane film compared with chlorhexidine‐impregnated paraffin gauze (P &lt; 0.01; results presented graphically). </p> </section> <section id="CD002106-sec-0110"> <h6 class="title">Incidence of infection</h6> <p>There was no significant difference in rates of wound infection between the two groups (1/26 (4%) with polyurethane film versus 2/25 (8%) with chlorhexidine‐impregnated paraffin gauze; RR 0.48, 95% CI 0.05 to 4.98; P = 0.54) (<a href="./references#CD002106-fig-0007" title="">Analysis 4.1</a>). </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, number of dressing changes, quality of life, length of hospital stay and need for surgery were not addressed by this study. </p> </section> <section id="CD002106-sec-0111"> <h6 class="title">Summary</h6> <p>Overall, there was some evidence that polyurethane film dressings may be more effective in healing partial thickness burns than chlorhexidine‐impregnated paraffin gauze dressings, although there is only poor quality evidence. </p> </section> </section> </section> <section id="CD002106-sec-0112"> <h4 class="title">3. Hydrogel dressings</h4> <section id="CD002106-sec-0113"> <h5 class="title">a. Hydrogel dressing compared with usual care (three trials, 235 people)</h5> <p>We found three RCTs which compared hydrogel dressings with usual care (either SSD, paraffin gauze or paraffin gauze with antibiotics) (<a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a>; <a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a>; <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a>). </p> <section id="CD002106-sec-0114"> <h6 class="title">Time to complete wound healing</h6> <p><a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a> found healing times to be shorter in the group allocated to the hydrogel dressing (mean wound healing times: 11.92 days (SD 5.91) with hydrogel dressing (n = 51) versus 13.55 days (SD 6.70) with usual care (n = 51); P &lt; 0.02). <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a> showed no statistical difference although a trend in favour of the hydrogel was noted (mean healing time: 13.6 days (SD 9.6) with hydrogel dressing versus 15.1 days (SD 6.45) with usual care; P = 0.07). </p> </section> <section id="CD002106-sec-0115"> <h6 class="title">Number of people healed</h6> <p><a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a> found significantly more people in the hydrogel treatment group had healed at nine days (RR 2.00, 95% CI 1.08 to 3.72; P = 0.03) (<a href="./references#CD002106-fig-0009" title="">Analysis 5.2</a>) and 12 days (RR 1.68, 95% CI 1.17 to 2.42; P = 0.005) (<a href="./references#CD002106-fig-0011" title="">Analysis 5.4</a>). No significant differences were found between the treatment groups in the number of people healed at six days, 15 days, 18 days and 21 days. </p> </section> <section id="CD002106-sec-0116"> <h6 class="title">Level of pain</h6> <p>Two studies report on pain at dressing application and removal. The tool used to describe pain assessment in the study by <a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a> was not described and data not reported, although it was reported narratively that pain following dressing application was reduced at days two, four and eight; P &lt; 0.0001. <a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a> reported pain assessments at baseline, 30 minutes after treatment, at days two, four and eight and an overall assessment at the end of the study. There was no significant difference between the groups at baseline but there was significant less pain in the hydrogel group at the end of the study (MD ‐1.31, 95% CI ‐2.37 to ‐0.25) (<a href="./references#CD002106-fig-0014" title="">Analysis 5.7</a>; <a href="./references#CD002106-fig-0016" title="">Analysis 5.9</a>). </p> </section> <section id="CD002106-sec-0117"> <h6 class="title">Number of dressing changes</h6> <p><a href="./references#CD002106-bbs2-0015" title="GuilbaudJ , HondeC . Multicentre comparative clinical study of a new wound dressing: PA286 (Inerpan). European Journal of Plastic Surgery1993;16:73‐6. ">Guilbaud 1993</a> found fewer dressing changes with the hydrogel dressings compared with the control (mean number of dressings reported graphically). <a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a> also found the rate of renewal (the ratio between healing time and number of dressings) was 8.2 days for the hydrogel dressing with 3.5 days for control sites. Twenty‐seven (51.9%) treated with a hydrogel dressing had one application whereas two treated (3.8%) in the control group had one application. </p> </section> <section id="CD002106-sec-0118"> <h6 class="title">Adverse events</h6> <p><a href="./references#CD002106-bbs2-0014" title="GuilbaudJ . European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. Burns1992;18(5):419‐22. ">Guilbaud 1992</a> noted the incidence of local events, especially exudate and suppuration and was similar with both groups, but only noticed 6/52 (11.5%) patients revealing positive bacteriological cultures. In the six patients (12 sites), three specimens were positive in the hydrogel sites versus six in the control sites. </p> </section> <section id="CD002106-sec-0119"> <h6 class="title">Infection with <i>Pseudomonas aeruginosa</i> requiring antibiotic therapy </h6> <p><a href="./references#CD002106-bbs2-0013" title="GrippaudoFR , CariniL , BaldiniR . Procutase versus 1% silver sulphadiazine in the treatment of minor burns. Burns2010;36(6):871‐5. ">Grippaudo 2010</a> found that there was no difference in the number of patients becoming infected with <i>Pseudomonas aeruginosa</i> that required antibiotic therapy (RR 0.33, 95% CI 0.01 to 7.95; P = 0.50)(<a href="./references#CD002106-fig-0017" title="">Analysis 5.10</a>). </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, quality of life, length of hospital stay and need for surgery were not addressed by these studies. </p> </section> <section id="CD002106-sec-0120"> <h6 class="title">Summary</h6> <p>Overall hydrogel dressings may heal partial thickness burns more quickly than usual care, although the evidence is of low quality. </p> </section> </section> </section> <section id="CD002106-sec-0121"> <h4 class="title">4. Silicon‐coated nylon dressings</h4> <section id="CD002106-sec-0122"> <h5 class="title">a. Silicon‐coated nylon dressings compared with silver sulphadiazine (two trials, 142 people) </h5> <section id="CD002106-sec-0123"> <h6 class="title">Time to complete wound healing</h6> <p>We found two RCTs which compared silicon‐coated nylon dressings with SSD (<a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a>; <a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a>). <a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a> found the mean time to full epithelialisation to be significantly shorter with silicon‐coated nylon dressings (mean healing time: 7.58 days (+/‐ 3.12) with silicone‐coated nylon versus 11.26 days (+/‐ 6.02) with silver sulphadiazine; P &lt; 0.01). <a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a> reported the median time to full epithelialisation to be shorter with silicon‐coated nylon dressings (median time to full re‐epithelialisation of the wound: 10.5 days with silicone mesh dressing compared with 27.6 days with SSD; P = 0.0002). No variance data were reported for this outcome. </p> </section> <section id="CD002106-sec-0124"> <h6 class="title">Level of pain</h6> <p><a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a> found that the silicon‐coated mesh nylon dressing reduced pain (measured on the Objective Pain Scale (OPS), where 0 = no pain and 10 = severe pain) in the first five days after injury compared with SSD (mean pain score over first five days on pain scale: 4.0 with silicone mesh dressing versus 4.9 with SSD; P &lt; 0.025). No variance data were reported for this outcome. They also found that mean pain score at dressing change (measured on the OPS) was significantly lower with silicone mesh dressing compared with SSD in the first five days after burn injury. <a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a> did not report on pain. </p> </section> <section id="CD002106-sec-0125"> <h6 class="title">Number of dressing changes</h6> <p><a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a> noted that there were significantly fewer dressing changes with silicone‐coated nylon net dressing than with SSD (3.64 with silicone‐coated nylon net dressing versus 5.13 with SSD; MD ‐1.49, 95% CI ‐2.64 to ‐0.34; P &lt; 0.01) (<a href="./references#CD002106-fig-0018" title="">Analysis 6.1</a>). As the dressings were changed every two to three days until complete healing was obtained, this result was not surprising but simply a result of the longer healing period with SSD. The RCT found no fluid collection, haematoma or secondary displacement in either group. </p> </section> <section id="CD002106-sec-0126"> <h6 class="title">Cost of the dressing</h6> <p><a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a> reported on resource use and noted that children treated with silicone‐coated nylon net dressing incurred lower total charges for dressing changes from USD 739 per hospitalisation versus USD 413 for those treated with SSD (P&lt;0.05). </p> </section> <section id="CD002106-sec-0127"> <h6 class="title">Adverse events</h6> <p><a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a> noted that SSD significantly increased the risk of moderate to severe eschar formation compared with silicone mesh dressing (42% with SSD versus 6% with silicone mesh dressing; P &lt; 0.0001). <a href="./references#CD002106-bbs2-0012" title="GotschallC , MorrisonM , EichelbergerM . Prospective, randomized study of the efficacy of Mepitel on children with partial‐thickness scalds. Journal of Burn Care and Rehabilitation1998;19(4):279‐83. ">Gotschall 1998</a> also noted that none of the wounds in either treatment arm exhibited signs of infection during the dressing changes. However, it was reported that wound cultures for children treated with silicone mesh dressing did yield both a wider variety of bacterial flora and larger amounts of bacterial growth. Three children in the silicone mesh dressing group developed fevers of unknown origin followed by a diffuse maculopapular rash. They were excluded from the RCT on a precautionary basis, although their wounds healed without complication. Treatment regimens for these three children were not reported. <a href="./references#CD002106-bbs2-0003" title="BugmannP , TaylorS , GygerD , LironiA , GeninB , VundaA , et al. A silicone‐coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial. Burns1998;24(7):609‐12. ">Bugmann 1998</a> reported one case of infection and two cases of bleeding in the SSD group, with one case of bleeding reported in the silicon dressing group. </p> <p>Other outcome measures such as change in wound surface area, quality of life, patient perception and level of satisfaction with application and removal of dressing, length of hospital stay and need for surgery were not addressed by these studies. </p> </section> <section id="CD002106-sec-0128"> <h6 class="title">Summary</h6> <p>Overall the evidence suggests that silicon‐coated nylon dressings may heal partial thickness burns more quickly than SSD, although there is only poor quality evidence. </p> </section> </section> </section> <section id="CD002106-sec-0129"> <h4 class="title">5. Biosynthetic skin substitute dressings</h4> <p>A total of 10 trials (11 comparisons) compared various biosynthetic dressings with a range of alternatives. </p> <section id="CD002106-sec-0130"> <h5 class="title">a. Biosynthetic dressings compared with silver sulphadiazine (six trials, 267 people)</h5> <section id="CD002106-sec-0131"> <h6 class="title">Time to complete wound healing</h6> <p>We found six studies that compared biosynthetic dressings with SSD. Five studies compared one type of biosynthetic dressing with SSD (<a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a>; <a href="./references#CD002106-bbs2-0023" title="NoordenbosJ , DoreC , HansbroughJF . Safety and efficacy of TransCyte for the treatment of partial‐thickness burns. Journal of Burn Care and Rehabilitation1999;20(4):275‐81. ">Noordenbos 1999</a>) and one study compared two different types of biosynthetic dressings with SSD in a three‐arm design. All six studies individually reported a significantly shorter wound healing time with the use of biosynthetic dressing compared with SSD. <a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a> noted mean healing times to be 9.7 days (+/‐ 0.7) with biosynthetic dressing (Biobrane) compared with 16.1 days (+/‐ 0.6) with SSD (P &lt; 0.001). <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a> found healing times to be 13.7 days (+/‐ 6.75) with biosynthetic dressing (Biobrane) compared with 21.3 days (+/‐ 11.03) with SSD (P &lt; 0.01). <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a> noted that, in their sample, the greatest difference in healing time was observed in grease/tar burns (mean healing time in biosynthetic dressing (Biobrane) group: 8.4 days (+/‐ 1.0) compared with 18.5 days (+/‐ 5.0) for those in the SSD group (P &lt; 0.02)). <a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a> reported on time to heal per percent total body surface area burned (in participants &lt; 3 years old: 1.52 days in biosynthetic dressing (Biobrane) compared with 2.35 days with SSD (P 0.025); in participants aged 3 to 17 years: 1.00 days in biosynthetic dressing compared with 2.40 days with SSD (P 0.026) (information presented graphically)). <a href="./references#CD002106-bbs2-0023" title="NoordenbosJ , DoreC , HansbroughJF . Safety and efficacy of TransCyte for the treatment of partial‐thickness burns. Journal of Burn Care and Rehabilitation1999;20(4):275‐81. ">Noordenbos 1999</a> included 14 people and identified paired wound sites which were randomised to treatment with a biosynthetic dressing (TransCyte) or SSD. The author reported on days until 90% healed and found that the biosynthetic dressing significantly reduced healing time compared with SSD (days until 90% healed: 11.14 days (SD 4.37) with biosynthetic dressing versus 18.14 days (SD 6.05) with SSD (paired t test P = 0.002). <a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a> randomised 33 people with 58 wound sites to three different burn dressings (TransCyte, Biobrane and SSD) Wound healing, measured as mean time to re‐epithelialisation, was 7.5 days for TransCyte; 9.5 days for Biobrane and 11.2 days for SSD (P &lt; 0.001). No variance data were reported. Healing progression was estimated visually by two independent observers but it was not reported whether or not they were blind to treatment allocation and this could be a source of bias. It was not appropriate to pool these studies due to heterogeneity, missing variance data, different types of burns and unit of analysis errors. </p> </section> <section id="CD002106-sec-0132"> <h6 class="title">Level of pain</h6> <p>Pain was assessed by <a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a>; <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a> and <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a> using scales of different magnitudes. <a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a> using a visual analogue scale plus face scale noted a difference in pre‐treatment pain baseline scores (3.3 for those randomised to biosynthetic dressing versus 3.8 for those assigned to SSD; P value not significant). Relief following dressing application was reduced to 2.4 with biosynthetic dressing and 3.7 with those assigned SSD at day 1; P &lt;0.001; and 2.6 with biosynthetic dressing and 3.8 with those assigned SSD at day 2; P &lt; 0.001. <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a> and <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a> noted a difference in pain scores (measured on a visual analogue scale using a five‐point scale with 1 = no pain and 5 = severe pain) at first follow‐up visit. Pooling these two trials using a random effects model (I<sup>2</sup> = 75.5%) demonstrated a statistically significant difference (MD ‐1.63, 95% CI ‐2.20 to ‐1.06) (<a href="./references#CD002106-fig-0019" title="">Analysis 7.1</a>). Although <a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a> did not report pain scores using any form of validated pain scale, patients treated with biosynthetic dressings required significantly fewer pain medications than those treated with SSD (P = 0.0001; type, route and dose of analgesia not reported).Pain was not reported by <a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a>. </p> <p>Out of interest, <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a> also found that patients in the biosynthetic dressing treatment arm used fewer pain relieving tablets than those receiving SSD (1.4 tablets in biosynthetic dressing versus 3.5 tablets in SSD; P &lt; 0.01, dosage and type of analgesic not reported). In the <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a> study, on average, fewer doses of narcotics were also given to those receiving biosynthetic dressing (12 doses in the biosynthetic dressing group versus 16.9 doses in the SSD group; P value not significant, dosage and type of analgesic not reported). <a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a> found similar results: (0.5 doses/person/day in biosynthetic dressing versus 1.9 doses/person/day with SSD; P &lt;0.002, dosage and type of analgesia not reported). </p> </section> <section id="CD002106-sec-0133"> <h6 class="title">Need for surgery</h6> <p><a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a> also noted that five participants (22%) in the SSD arm obtained split‐thickness skin graft to close the granulation defects compared with four patients (15%) who were treated with biosynthetic dressing (RR 0.68; 95% CI 0.21 to 2.24;P = 0.53) (<a href="./references#CD002106-fig-0020" title="">Analysis 7.2</a>). <a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a> found that there were five wounds in the SSD group that required auto‐grafting, three in the Biobrane and one in the TransCyte group. Patients treated with biosynthetic dressings underwent auto‐grafting due to infection and loss of product. Patients treated with SSD underwent grafting due to delay to re‐epithelialisation. </p> </section> <section id="CD002106-sec-0134"> <h6 class="title">Length of hospital stay</h6> <p><a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a> noted that hospital length of stay was shorter in those receiving biosynthetic dressing compared with SSD in both toddlers and infants (age 0 to 3 years; P = 0.002) and older children (age &gt; 3 years; P = 0.0026). </p> </section> <section id="CD002106-sec-0135"> <h6 class="title">Incidence of infection</h6> <p>Wound infection and other systemic complications were reported in three studies (<a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a>; <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a>; <a href="./references#CD002106-bbs2-0023" title="NoordenbosJ , DoreC , HansbroughJF . Safety and efficacy of TransCyte for the treatment of partial‐thickness burns. Journal of Burn Care and Rehabilitation1999;20(4):275‐81. ">Noordenbos 1999</a>). The remaining studies reported no infection (<a href="./references#CD002106-bbs2-0002" title="BarretJP , DziewulskiP , RamzyP , WolfS , DesaiMH , HerndonD . Biobrane versus 1% silver sulfadiazine in second‐degree pediatric burns. Plastic and Reconstructive Surgery2000;105(1):62‐5. ">Barret 2000</a>) or only suspected, but not confirmed (<a href="./references#CD002106-bbs2-0019" title="LalS , BarrowR , WolfS , ChinkesD , HartD , HeggersJ , et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock1999;14(3):314‐9. ">Lal 1999</a>). Infection was poorly defined by many of the studies. <a href="./references#CD002106-bbs2-0009" title="GerdingRL , ImbemboAL , FratianneRB . Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment of inpatient partial‐thickness thermal burns. Journal of Trauma1988;28(8):1265‐9. ">Gerding 1988</a> reported the development of bacterial growth in four wounds in each group with two of the infected in each group requiring surgical excision and grafting. <a href="./references#CD002106-bbs2-0010" title="GerdingRL , EmermanCL , EffronD , LukensT , ImbemboAL , FratianneRB . Outpatient management of partial‐thickness burns: Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine1990;19(2):29‐32. ">Gerding 1990</a> noted that there were three infections in those patients assigned to biological dressings and two infections in those assigned to SSD. One patient in each group required skin grafting. <a href="./references#CD002106-bbs2-0023" title="NoordenbosJ , DoreC , HansbroughJF . Safety and efficacy of TransCyte for the treatment of partial‐thickness burns. Journal of Burn Care and Rehabilitation1999;20(4):275‐81. ">Noordenbos 1999</a> noted that six patients developed mild cellulitis in the SSD arm of the trial, and all incidents responded to intravenous antibiotics. No wounds became infected during treatment with the biosynthetic dressing. </p> <p><b>Number of dressing changes</b> </p> <p><a href="./references#CD002106-bbs2-0018" title="KumarRJ , KimbleRM , BootsR , PeggSP . Treatment of partial thickness burns: a prospective randomised trial using transcyte. ANZ Journal of Surgery2004;74(8):622‐6. ">Kumar 2004</a> found fewer dressing changes with either TransCyte or Biobrane compared with SSD. The number of dressing changes: 1.5 with TransCyte and 2.4 with Biobrane compared with 9.2 with Silvazene cream (P &lt; 0.0001). </p> <p>Other outcome measures such as change in wound surface area, cost of the dressing and quality of life were not addressed by these studies. </p> <p><b>Summary</b> </p> <p>Overall there is consistent evidence that biosynthetic dressings are more effective than SSD, although there is only poor quality evidence. </p> </section> </section> <section id="CD002106-sec-0136"> <h5 class="title">b. Biosynthetic dressing (Biobrane) compared with hydrocolloid dressing (one trial, 72 people) </h5> <section id="CD002106-sec-0137"> <h6 class="title">Time to complete wound healing</h6> <p>We found one study by <a href="./references#CD002106-bbs2-0005" title="CassidyC , StPeterSD , LaceyS , BeeyM , Ward‐SmithP , SharpRJ , et al. Biobrane versus Duoderm for the treatment of intermediate thickness burns in children: a prospective randomized trial. Burns2005;31(7):890‐3. ">Cassidy 2005</a> which compared a biosynthetic dressing with a hydrocolloid dressing. No significant difference was found between the biosynthetic dressing and the hydrocolloid dressing in mean time to wound healing: 12.24 days with the biosynthetic dressing compared with 11.21 days for the hydrocolloid dressing (MD 1.03, 95% CI ‐1.66 to 3.72; P = 0.45). </p> </section> <section id="CD002106-sec-0138"> <h6 class="title">Level of pain</h6> <p>Pain assessment was performed using the Oucher Scale in 34 participants and the VAS utilised for the remaining 37 patients. The study authors do not make it clear if the use of these two scales was balanced across both groups. <a href="./references#CD002106-bbs2-0005" title="CassidyC , StPeterSD , LaceyS , BeeyM , Ward‐SmithP , SharpRJ , et al. Biobrane versus Duoderm for the treatment of intermediate thickness burns in children: a prospective randomized trial. Burns2005;31(7):890‐3. ">Cassidy 2005</a> noted no statistically significant difference in mean aggregate scores (2.36 for those randomised to biosynthetic dressing versus 2.37 with hydrocolloid dressing; P = 0.99). </p> </section> <section id="CD002106-sec-0139"> <h6 class="title">Cost of the dressing</h6> <p><a href="./references#CD002106-bbs2-0005" title="CassidyC , StPeterSD , LaceyS , BeeyM , Ward‐SmithP , SharpRJ , et al. Biobrane versus Duoderm for the treatment of intermediate thickness burns in children: a prospective randomized trial. Burns2005;31(7):890‐3. ">Cassidy 2005</a> reported that cost of each treatment was higher in the biosynthetic dressing group, regardless of the size or thickness of the dressing (P &lt; 0.0001). This cost was obvious and not unexpected given the nature of biosynthetic dressing technology compared with older, simpler dressings such as a hydrocolloid. </p> <p>Other outcome measures such as change in wound surface area, number of dressing changes, adverse events, quality of life, need for surgery and patient perception and level of satisfaction with application and removal of dressing were not addressed by this study. </p> </section> <section id="CD002106-sec-0140"> <h6 class="title">Summary</h6> <p>Overall there was no evidence of a difference in burn healing between biosynthetic dressings and hydrocolloid dressings, although the single trial was poorly reported and may be at risk of bias. </p> </section> </section> <section id="CD002106-sec-0141"> <h5 class="title">c. Antimicrobial‐releasing biosynthetic dressings (Hydron) compared with silver sulphadiazine or other agents (three trials, 95 people) </h5> <section id="CD002106-sec-0142"> <h6 class="title">Time to complete wound healing</h6> <p>We found three RCTs which compared antimicrobial‐releasing biosynthetic dressings with SSD (<a href="./references#CD002106-bbs2-0007" title="CurreriPW , DesaiM , BartlettR , HeimbachD , ParshleyP , TrunkeyD . Safety and efficacy of a new synthetic burn dressing: a multicenter study. Archives of Surgery1980;115(8):925‐7. ">Curreri 1980</a>; <a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a>; <a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a>). <a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a> reported average healing times to be significantly shorter with antimicrobial releasing biosynthetic dressing (6.8 days) compared with 11.7 days with SSD; P value and variance data not reported. <a href="./references#CD002106-bbs2-0007" title="CurreriPW , DesaiM , BartlettR , HeimbachD , ParshleyP , TrunkeyD . Safety and efficacy of a new synthetic burn dressing: a multicenter study. Archives of Surgery1980;115(8):925‐7. ">Curreri 1980</a> reported time to complete wound healing to be more rapid in wounds covered with antimicrobial releasing biosynthetic dressing rather than SSD (numerical or graphical data not provided; P value not reported). </p> </section> <section id="CD002106-sec-0143"> <h6 class="title">Number of dressing changes</h6> <p><a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a> noted that on average there were 93 dressing applications making it an average of more than three dressings per patient. In most patients (number of patients not reported), the antimicrobial‐releasing biosynthetic dressing remained in place for almost four days, in the same time period the control site required four dressing changes. Although the number of dressing changes was not stated by <a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a>, the authors reported on their response to the dressing. Treating nurses and participants rated the antimicrobial releasing biosynthetic dressing more highly than the control using the classification favourable, unfavourable or no difference. Favourable ratings were self‐assessed and proportion of treating nurses in favour was: 41/50 (82%) treating nurses versus 34/50 (68%) patients; unfavourable: 9/50 (18%) treating nurses versus 11/50 (22%) patients and no difference was recorded in 5/50 (10%) of patients. </p> </section> <section id="CD002106-sec-0144"> <h6 class="title">Patient perception, level of satisfaction with the application and removal of dressing</h6> <p>In contrast, <a href="./references#CD002106-bbs2-0007" title="CurreriPW , DesaiM , BartlettR , HeimbachD , ParshleyP , TrunkeyD . Safety and efficacy of a new synthetic burn dressing: a multicenter study. Archives of Surgery1980;115(8):925‐7. ">Curreri 1980</a> reported that 81% of the sample population found that the antimicrobial‐releasing biosynthetic dressing was more difficult and time‐consuming to apply than SSD (definition and description of difficulty not provided; number of minutes defining time‐consuming not reported). </p> </section> <section id="CD002106-sec-0145"> <h6 class="title">Need for surgery</h6> <p><a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a> noted that eight patients in the antimicrobial releasing biosynthetic dressing required grafting and seven in the SSD group. </p> </section> <section id="CD002106-sec-0146"> <h6 class="title">Incidence of infection</h6> <p><a href="./references#CD002106-bbs2-0017" title="HusainMT , AktarM , AkhtarN . Report on evaluation of hydron film as burn wound dressing. Burns1983;9(5):330‐4. ">Husain 1983</a> noted that wound infection developed in 15/50 (30%) sites treated with antimicrobial‐releasing biosynthetic dressing and 8/50 (16%) sites for those treated with SSD; this difference was not statistically significant (RR 1.88 95%CI 0.87 to 4.02; P = 0.11) (<a href="./references#CD002106-fig-0021" title="">Analysis 8.1</a>). <a href="./references#CD002106-bbs2-0008" title="FangC , NathanP , RobbE , AlexanderJ , MacMillanB . Prospective clinical study of Hydron, a synthetic dressing, in delivery of an antimicrobial drug to second‐degree burns. Journal of Burn Care and Rehabilitation1987;8(3):206‐9. ">Fang 1987</a> reported on bacterial colonisation rather than infection. </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, quality of life and length of hospital stay were not addressed by these studies. </p> </section> <section id="CD002106-sec-0147"> <h6 class="title">Summary</h6> <p>Overall we found some evidence that antimicrobial‐releasing biosynthetic dressings may heal burns more quickly than SSD or other agents, although the evidence is generally of poor quality </p> </section> </section> </section> <section id="CD002106-sec-0148"> <h4 class="title">6. Antimicrobial (silver‐containing) dressings</h4> <section id="CD002106-sec-0149"> <h5 class="title">a. Silver‐impregnated dressings compared with silver sulphadiazine (five trials, 331 patients) </h5> <p>We found five RCTs which compared silver‐impregnated dressing (Acticoat, Smith and Nephew USA) with SSD (<a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a>; <a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a>; <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>; <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a>; <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a>). </p> <section id="CD002106-sec-0150"> <h6 class="title">Time to complete wound healing</h6> <p><a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a> and <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a> found mean healing time significantly shorter in those patients treated with silver dressings compared with SSD. We have pooled these studies as they appear to report on all wounds until complete healing (MD ‐4.22, 95% CI ‐5.92 to ‐2.52; P &lt; 0.00001) (<a href="./references#CD002106-fig-0022" title="">Analysis 9.1</a>). <a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a> also found mean healing time to be significantly shorter in the intervention group, but we have not included this study in the meta‐analysis because of censored data. <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a> and <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a> did not report on time to complete wound healing. </p> </section> <section id="CD002106-sec-0151"> <h6 class="title">Number of people healed</h6> <p><a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a> found that the number of people healed at seven days, 10 days and 17 days was not significantly different for silver dressings compared with SSD (<a href="./references#CD002106-fig-0023" title="">Analysis 9.2</a>; <a href="./references#CD002106-fig-0024" title="">Analysis 9.3</a>; <a href="./references#CD002106-fig-0026" title="">Analysis 9.5</a>). However, at 15 days, <a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a> and Huang 2007 found that the number of people healed was significantly more for silver dressings than SSD (RR 1.17, 95% CI 1.02 to 1.35; P = 0.03) (<a href="./references#CD002106-fig-0025" title="">Analysis 9.4</a>) and at 21 days <a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a> also found a significant effect in favour of silver dressings (RR 1.21, 95% CI 1.06 to 1.37; P = 0.004) (<a href="./references#CD002106-fig-0027" title="">Analysis 9.6</a>). </p> </section> <section id="CD002106-sec-0152"> <h6 class="title">Healing rate</h6> <p><a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a> found that there was no difference in the rate of healing between silver dressings and SSD (MD 2.21, 95% CI ‐2.37 to 6.79; P = 0.34) (<a href="./references#CD002106-fig-0028" title="">Analysis 9.7</a>). </p> </section> <section id="CD002106-sec-0153"> <h6 class="title">Level of pain</h6> <p>The studies by <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a>, <a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a> and <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a> found that silver‐impregnated dressings reduced pain (measured on a visual analogue scale (VAS ‐ scale 1 to 10) compared with SSD. These trials were pooled using a random‐effects model due to the high level of heterogeneity (I<sup>2</sup> = 81%) and the difference was not statistically significant (MD ‐2.84; 95% CI ‐5.89 to 0.21) (<a href="./references#CD002106-fig-0029" title="">Analysis 9.8</a>). </p> </section> <section id="CD002106-sec-0154"> <h6 class="title">Need for surgery</h6> <p><a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a> noted that six participants (24%) in the SSD arm obtained split‐thickness skin graft to close the granulation defects compared with four patients (16%) who were treated with silver dressing (RR 0.67; 95% CI 0.21 to 2.08 P = 0.48) (<a href="./references#CD002106-fig-0030" title="">Analysis 9.9</a>). </p> </section> <section id="CD002106-sec-0155"> <h6 class="title">Hospital length of stay</h6> <p><a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a> reported no difference in hospital length of stay between the two groups. </p> </section> <section id="CD002106-sec-0156"> <h6 class="title">Incidence of infection</h6> <p><a href="./references#CD002106-bbs2-0011" title="GongZ , YaoJ , JiJ , YangJ , XiangT . Effect of ionic silver dressing combined with hydrogel on degree II burn wound healing [zhong guo zu zhi gong cheng yan jiu yu lin chuang kang fu]. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(42):8373‐6. ">Gong 2009</a>, <a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a>, <a href="./references#CD002106-bbs2-0020" title="MuangmanP , ChuntrasakulC , SilthramS , SuvanchoteS , BenjathanungR , KittidachaS , et al. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial‐thickness burn wounds. Journal of the Medical Association of Thailand2006;89(7):953‐8. ">Muangman 2006</a> and <a href="./references#CD002106-bbs2-0028" title="VarasRP , O'KeefeT , NamiasN , PizanoLR , QuintananOD , TellacheaMH , et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. Journal of Burn Care and Rehabilitation2005;26(4):344‐7. ">Varas 2005</a> found that there was no significant difference between silver dressings and SSD in the number of infections (RR 1.04, 95% CI 0.64 to 1.67) (<a href="./references#CD002106-fig-0031" title="">Analysis 9.10</a>). </p> <p><a href="./references#CD002106-bbs2-0016" title="HuangY , LiX , LiaoZ , ZhangG , LiuQ , TangJ , et al. A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis. Burns2007;33(2):161‐6. HuangYS , LiXL , LiaoZJ , ZhangGA , LiuQ , TangJ , et al. Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds: summary report. Institute of Burn Research, Southwest Hospital, The Third Military Medical University2004. LiXL , HuangYS , PengYZ , LiaoZJ , ZhangGA , LiuQ . Multi‐center clinical study of Acticoat (nanocrystalline silver dressing) for the management of residual burn wounds. Chinese Journal of Burns2006;22(1):15‐8. ">Huang 2004</a> found a total of 56 bacterial strains in 166 wounds which cleared on the 6th and 12th day post antibiotic treatment. </p> </section> <section id="CD002106-sec-0157"> <h6 class="title">Number of wound dressings</h6> <p><a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a> found that there were significantly fewer wound dressings used for silver dressings than for SSD (MD ‐11.07, 95% CI ‐19.58 to ‐2.56; P = 0.01) (<a href="./references#CD002106-fig-0032" title="">Analysis 9.11</a>). </p> </section> <section id="CD002106-sec-0158"> <h6 class="title">Nursing time</h6> <p><a href="./references#CD002106-bbs2-0024" title="OpasanonS , MuangmanP , NamviriyachoteN . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. International Wound Journal2010;7(6):467‐71. OpasanonS , MuangmanP , NamviriyachoteN , ChuntrasakulC . Clinical effectiveness of alginate silver dressing in outpatient management of partial‐thickness burns. EWMA Journal 2010;10(2):148. ">Opasanon 2010</a> found that there was no difference in nursing time between the silver dressing group and the SSD group (MD ‐4.82, 95% CI ‐19.42 to 9.78; P = 0.52) (<a href="./references#CD002106-fig-0033" title="">Analysis 9.12</a>). </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, quality of life, patient perception and level of satisfaction with application and removal of dressing were not addressed by these studies. </p> </section> <section id="CD002106-sec-0159"> <h6 class="title">Summary</h6> <p>Overall there was evidence that silver‐impregnated dressings heal burns more quickly than SSD, although the evidence is of poor quality. </p> </section> </section> </section> <section id="CD002106-sec-0160"> <h4 class="title">7. Fibre dressings</h4> <section id="CD002106-sec-0161"> <h5 class="title">a. Calcium alginate compared with silver sulphadiazine (one trial, 59 people)</h5> <section id="CD002106-sec-0162"> <h6 class="title">Time to complete wound healing</h6> <p>We found one RCT by <a href="./references#CD002106-bbs2-0006" title="CostagliolaM , CastedeJC , ChaouatM , MimounM , PannierM , Pellerin Petal . Algosteril dressing (calcium alginate) versus Flammazine (silver sulphadiazine) in the treatment of second‐degree burns. Fourth Australian Wound Management Association Conference. 2002:53. ">Costagliola 2002</a> (59 people with 73 partial thickness burns) which compared calcium alginate with SSD. It found no significant difference between calcium alginate and SSD in time to healing (12.1 days with calcium alginate versus 11.7 days with SSD; P value and variance data not reported). </p> <p>The author states that he found no significant difference between groups in terms of pain and the amount of care required (however pain scale assessment and scores not provided; definition of amount of care are not described). </p> <p>Other outcome measures such as change in wound surface area, cost of the dressings, quality of life, patient perception and level of satisfaction with application and removal of dressing, and length of hospital stay were not addressed by this study. </p> </section> <section id="CD002106-sec-0163"> <h6 class="title">Summary</h6> <p>Overall there was no evidence that calcium alginate dressings are more effective than SSD, although the evidence is of poor quality. </p> </section> </section> <section id="CD002106-sec-0164"> <h5 class="title">b. Hydrofibre dressing compared with silver sulphadiazine (two trials, 154 people)</h5> <section id="CD002106-sec-0165"> <h6 class="title">Time to complete wound healing</h6> <p><a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a> found a significantly shorter healing time for hydrogel fibre dressing when compared with SSD (MD ‐3.70, 95% CI ‐5.44 to ‐1.96; P &lt; 0.0001) (<a href="./references#CD002106-fig-0034" title="">Analysis 10.1</a>). <a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a> also compared a hydrogel fibre dressing with SSD. No significant difference was found between the hydrogel dressing and SSD in time to wound healing: median wound healing time 16 days with hydrogel fibre versus 17 days with SSD; P = 0.517. However, these data were not pooled as no variance data were reported. </p> </section> <section id="CD002106-sec-0166"> <h6 class="title">Level of pain</h6> <p><a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a> evaluated pain using the Johns Hopkins visual analogue scale for those aged four years and older and investigator‐reported pain scores for the pre‐verbal population. Hydrogel fibre dressing reduced pain during dressing changes (mean pain score: 3.63 with hydrogel fibre dressing versus 4.77 with SSD; P = 0.003). There was no difference in the investigator‐reported pain scores between the hydrogel fibre and SSD groups (mean pain scores 3.52 with hydrogel fibre dressing versus 3.32 with SSD; P = 0.991). Fewer types of procedural medications (2.4 doses versus 3.4 doses; P = 0.18; and procedural opiates (1.5 doses versus 2.1 doses; P = 0.022) were administered in the hydrogel fibre dressing group compared with the SSD group. Drug names, routes and dosages were not reported. </p> <p><a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a> evaluated level of pain on a 10‐point Likert scale and found that hydrofibre was superior to SSD in the level of pain at day one (MD ‐2.00, 95% CI ‐3.03 to ‐0.97; P = 0.0001) (<a href="./references#CD002106-fig-0035" title="">Analysis 10.2</a>), day three (MD ‐3.10, 95% CI ‐4.02 to ‐2.18; P &lt; 0.00001) (<a href="./references#CD002106-fig-0036" title="">Analysis 10.3</a>) and day seven (MD ‐2.40, 95% CI ‐3.18 to ‐1.62; P &lt; 0.00001) (<a href="./references#CD002106-fig-0037" title="">Analysis 10.4</a>). </p> </section> <section id="CD002106-sec-0167"> <h6 class="title">Number of dressing changes</h6> <p><a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a> found fewer dressing changes with hydrogel fibre dressing compared with SSD (mean number of dressing changes: 7.7 with hydrogel fibre dressing versus 19.1 with SSD (MD ‐11.40, 95% CI ‐15.66 to ‐7.14; P &lt;0.0001) (<a href="./references#CD002106-fig-0038" title="">Analysis 10.5</a>). However, this result was to be expected, as SSD dressings were changed routinely, whereas there was no indication to change hydrogel fibre dressings other than every second day. Dressing application, comfort of dressing and patient comfort were not significantly different between treatment groups. </p> </section> <section id="CD002106-sec-0168"> <h6 class="title">Cost of dressings</h6> <p>Mean total cost of primary dressings during the study was significantly greater for the hydrogel fibre dressing than for SSD (mean cost of primary dressing: USD 684 with hydrogel fibre dressings versus USD 398 in SSD group; P = 0.007). As expected, the mean cost for the secondary dressing (i.e. gauze dressing application over primary dressing) was lower for the hydrogel fibre group than the SSD group (mean secondary cost USD 68.10 with hydrogel fibre dressings versus USD138.00 in SSD group; P = 0.004). When total treatment costs were compared, costs were comparable amongst the two groups (mean total dressing cost: USD 848.50 with hydrogel fibre dressing versus USD 759.60 with SSD group). </p> </section> <section id="CD002106-sec-0169"> <h6 class="title">Incidence of infection</h6> <p><a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a> noted similar rates of wound infection in the two treatment groups (8/42 with hydrogel fibre dressing compared with 6/40 with SSD; RR 1.27, 95% CI 0.48 to 3.34) (<a href="./references#CD002106-fig-0039" title="">Analysis 10.6</a>). Patients who developed infections were treated with antibiotics. </p> </section> <section id="CD002106-sec-0170"> <h6 class="title">Need for surgery</h6> <p>The need for skin grafting due to re‐classification of a partial thickness burn as a full thickness burn or because of infection was required in both groups (5.04/42 (12%) with hydrogel fibre dressing versus 7.2/40 (18%) SSD (RR 0.68, 95% CI 0.24 to 1.97; P = 0.48) (<a href="./references#CD002106-fig-0040" title="">Analysis 10.7</a>). </p> <p>Other outcome measures such as change in wound surface area, quality of life and length of hospital stay were not addressed by this study. </p> </section> <section id="CD002106-sec-0171"> <h6 class="title">Summary</h6> <p>Overall there was no clear difference between hydrofibre dressings and SSD, although the trials were of poor quality. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD002106-sec-0172" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD002106-sec-0172"></div> <p>This systematic review summarises the best available evidence relating to the effects of dressings used to treat superficial or partial thickness burns. A total of 30 randomised controlled trials met the inclusion criteria for the review. Overall the quality of the evidence for dressings for burns is low, comprising small studies which are poorly reported and at risk of bias. </p> <p>Trial results suggest that burn wounds dressed with hydrogel dressings healed more rapidly than those dressed with a variety of usual care regimens. We also found evidence that burn wounds dressed with silicon‐coated dressings, biosynthetic dressings and silver‐impregnated dressings heal more rapidly than those dressed with SSD dressings.There is inadequate evidence to determine the effects of hydrocolloids and polyurethane dressings; five studies out of the seven included (<a href="./references#CD002106-bbs2-0001" title="AfilaloM , DankoffJ , GuttmanA , LloydJ . DuoDERM hydroactive dressing vs silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. Burns1992;18(4):313‐6. ">Afilalo 1992</a>; <a href="./references#CD002106-bbs2-0025" title="PhippsA , LawrenceJB . Comparison of hydrocolloid dressings and medicated tulle‐gras in the treatment of outpatient burns. In: RyanTJ editor(s). Beyond Occlusion: Wound Care Proceedings, Royal Society of Medicine Services International Congress and Symposium Series No. 136. London: RSM Services Ltd, 1988. ">Phipps 1988</a>; <a href="./references#CD002106-bbs2-0026" title="PoulsenT , FreundK , ArendrupK , NyhuusP , PedersenO . Polyurethane film vs impregnated gauze in the treatment of outpatient burns: a prospective, randomized study. Burns1991;17(1):59‐61. ">Poulsen 1991</a>; <a href="./references#CD002106-bbs2-0027" title="ThomasSS , LawrenceJC , ThomasA . Evaluation of hydrocolloids and topical medication in minor burns. Journal of Wound Care1995;4(5):218‐20. ">Thomas 1995</a>; <a href="./references#CD002106-bbs2-0029" title="WrightA , MacKechnieDW , PaskinsJR . Management of partial thickness burns with Granuflex 'E' dressings. Granuflex 'E' vs Bactigras. Burns1993;19(2):128‐30. ">Wright 1993</a>) found no statistically significant difference between the intervention and control groups. One study suggested that fibre dressings improve rates of healing when hydrofibre dressing is compared with SSD (<a href="./references#CD002106-bbs2-0021" title="MuangmanP , PundeeC , OpasanonS , MuangmanS . A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. International Wound Journal2010;7(4):271‐6. ">Muangman 2010</a>), although <a href="./references#CD002106-bbs2-0004" title="CarusoDM , FosterKN , Blome‐EberweinSA , TwomeyJA , HerndonDN , LutermanA , et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial‐thickness burns. Journal of Burn Care and Research2006;27(3):298‐309. ">Caruso 2006</a> did not find a difference in the rates of healing; there was no evidence that calcium alginate fibre dressing had reduced healing times compared to SSD. There was no evidence of a difference in healing time between biosynthetic dressings and hydrocolloids. </p> <p>There was some evidence that the pain experienced by patients (where reported) appeared to be reduced with the use of the intervention dressing against comparator dressings. This finding was not statistically significant in all studies but was consistent for all intervention dressings, except antimicrobial dressings where the difference was not significant. There was no significant difference in pain levels between biosynthetic dressings and hydrocolloids when compared directly. </p> <p>The evidence for the effectiveness of the different dressings for protecting from wound infection is limited by the inconsistent measurement and reporting of this outcome. Where infection rates are reported there does not appear to be a significant difference between intervention dressings and comparison groups. </p> <p>The number of dressing changes required appeared to favour several of the intervention dressings.  This difference was however also a reflection of different protocol regimens with SSD gauze dressings requiring daily changes and intervention dressings changed as required. </p> <p>These results, however, must be interpreted with caution. The included studies were generally of very poor quality and poorly reported. In many cases the number of people included in the trials was small and the time to wound healing data and subsequent statistical analysis were often not reported in a way that allowed the results to be reproduced by the review authors. Time to burn healing is invariably treated as a continuous outcome rather than a time to event outcome with censoring; however it is often unclear whether (a) all participants were fully followed up and (b) all healed. If either or both of these conditions are not met then it is incorrect to treat the time to event as continuous in nature. </p> <p>The quality of the evidence provided by these studies was low and limited in the following ways: </p> <p>a. Poor clinical definition of a superficial or partial thickness burn injury in many studies. <br/> b. Unreported burn depth estimates or no formal or direct assessment of burn wound depth. This may have erroneously led to the inclusion of a number of studies that were a mixture of various burn depths. <br/> c. Failure to report on randomisation techniques and allocation concealment, small sample sizes, subjective outcome assessment, lack of blinding at outcome assessment and poor reporting of withdrawals and adverse events data. <br/> d. Poor measurement of outcomes that are important, such as levels of pain, patient satisfaction, wound infection and scar appearance. The limited use of objective outcome measures and insufficient reporting of results makes the analysis and usefulness of these results doubtful.  </p> <p>In conclusion, a number of dressings may have some benefit over other products in the management of superficial and partial thickness burns. This advantage relates to time to wound healing, the number of dressing changes and pain experienced. However our confidence in these conclusions is reduced by the low quality of the evidence and small sample sizes of these trials.  </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD002106-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002106-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002106-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/full#CD002106-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hydrocolloid dressing vs chlorhexidine‐impregnated gauze dressing, Outcome 1 Withdrawal due to wound infection." data-id="CD002106-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Hydrocolloid dressing vs chlorhexidine‐impregnated gauze dressing, Outcome 1 Withdrawal due to wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hydrocolloid dressing vs silver sulphadiazine, Outcome 1 Number of dressing changes." data-id="CD002106-fig-0004" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Hydrocolloid dressing vs silver sulphadiazine, Outcome 1 Number of dressing changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hydrocolloid dressing vs silver sulphadiazine, Outcome 2 Level of pain." data-id="CD002106-fig-0005" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Hydrocolloid dressing vs silver sulphadiazine, Outcome 2 Level of pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Polyurethane film dressing vs paraffin gauze dressing, Outcome 1 Wound infection." data-id="CD002106-fig-0006" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Polyurethane film dressing vs paraffin gauze dressing, Outcome 1 Wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Polyurethane film dressing vs chlorhexidine‐impregnated paraffin gauze dressing, Outcome 1 Wound infection." data-id="CD002106-fig-0007" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Polyurethane film dressing vs chlorhexidine‐impregnated paraffin gauze dressing, Outcome 1 Wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 1 Wound healing: number of people healed at 6 days." data-id="CD002106-fig-0008" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 1 Wound healing: number of people healed at 6 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 2 Wound healing: number of people healed at 9 days." data-id="CD002106-fig-0009" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 2 Wound healing: number of people healed at 9 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 3 Wound healing: number of people healed at 21 days." data-id="CD002106-fig-0010" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 3 Wound healing: number of people healed at 21 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 4 Wound healing: number of people healed at 12 days." data-id="CD002106-fig-0011" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 4 Wound healing: number of people healed at 12 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 5 Wound healing: number of people healed at 15 days." data-id="CD002106-fig-0012" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 5 Wound healing: number of people healed at 15 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 6 Wound healing: number of people healed at 18 days." data-id="CD002106-fig-0013" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 6 Wound healing: number of people healed at 18 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 7 Assessment of pain at baseline." data-id="CD002106-fig-0014" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 7 Assessment of pain at baseline.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 8 Pain 30 minutes after treatment." data-id="CD002106-fig-0015" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 8 Pain 30 minutes after treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 9 Overall assessment of pain at end of study." data-id="CD002106-fig-0016" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 9 Overall assessment of pain at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Hydrogel dressing vs usual care, Outcome 10 Infection with Pseudomonas aeruginosa requiring antibiotic therapy." data-id="CD002106-fig-0017" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Hydrogel dressing vs usual care, Outcome 10 Infection with Pseudomonas aeruginosa requiring antibiotic therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Silicon nylon dressing vs silver sulphadiazine, Outcome 1 Number of dressing changes." data-id="CD002106-fig-0018" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Silicon nylon dressing vs silver sulphadiazine, Outcome 1 Number of dressing changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biosynthetic skin substitute (Biobrane) vs silver sulphadiazine, Outcome 1 Pain." data-id="CD002106-fig-0019" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Biosynthetic skin substitute (Biobrane) vs silver sulphadiazine, Outcome 1 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Biosynthetic skin substitute (Biobrane) vs silver sulphadiazine, Outcome 2 Need for surgery." data-id="CD002106-fig-0020" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Biosynthetic skin substitute (Biobrane) vs silver sulphadiazine, Outcome 2 Need for surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Antimicrobial‐releasing biosynthetic dressings vs silver sulphadiazine, Outcome 1 Wound infection." data-id="CD002106-fig-0021" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Antimicrobial‐releasing biosynthetic dressings vs silver sulphadiazine, Outcome 1 Wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 1 Wound healing time (days)." data-id="CD002106-fig-0022" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 1 Wound healing time (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 2 Wound healing: number of people healed at 7 days." data-id="CD002106-fig-0023" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 2 Wound healing: number of people healed at 7 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 3 Wound healing: number of people healed at 10 days." data-id="CD002106-fig-0024" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 3 Wound healing: number of people healed at 10 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 4 Wound healing: number of people healed at 15 days." data-id="CD002106-fig-0025" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 4 Wound healing: number of people healed at 15 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 5 Wound healing: number of people healed at 17 days." data-id="CD002106-fig-0026" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 5 Wound healing: number of people healed at 17 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 6 Wound healing: number of people healed at 21 days." data-id="CD002106-fig-0027" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 6 Wound healing: number of people healed at 21 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 7 Healing rate (% wound area)." data-id="CD002106-fig-0028" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 7 Healing rate (% wound area). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 8 Pain." data-id="CD002106-fig-0029" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 8 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 9 Need for surgery." data-id="CD002106-fig-0030" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.9</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 9 Need for surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 10 Number of infections." data-id="CD002106-fig-0031" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.10</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 10 Number of infections. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 11 Number of wound dressings." data-id="CD002106-fig-0032" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.11</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 11 Number of wound dressings. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-009-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-009-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 12 Nursing time (minutes)." data-id="CD002106-fig-0033" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.12</div> <div class="figure-caption"> <p>Comparison 9 Silver‐impregnated dressing vs silver sulphadiazine, Outcome 12 Nursing time (minutes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-009-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 1 Wound healing time (days)." data-id="CD002106-fig-0034" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 1 Wound healing time (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 2 Pain at day 1." data-id="CD002106-fig-0035" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 2 Pain at day 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 3 Pain at day 3." data-id="CD002106-fig-0036" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 3 Pain at day 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 4 Pain at day 7." data-id="CD002106-fig-0037" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 4 Pain at day 7.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 5 Number of dressing changes." data-id="CD002106-fig-0038" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 5 Number of dressing changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-010-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-010-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 6 Number of infections." data-id="CD002106-fig-0039" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 6 Number of infections.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002106-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/urn:x-wiley:14651858:media:CD002106:CD002106-CMP-010-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_t/tCD002106-CMP-010-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 7 Need for surgery." data-id="CD002106-fig-0040" src="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10 Fibre dressing vs silver sulphadiazine, Outcome 7 Need for surgery.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/media/CDSR/CD002106/image_n/nCD002106-CMP-010-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hydrocolloid dressing vs chlorhexidine‐impregnated gauze dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Withdrawal due to wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.53 [0.11, 59.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hydrocolloid dressing vs chlorhexidine‐impregnated gauze dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Hydrocolloid dressing vs silver sulphadiazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of dressing changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐18.65 [‐22.54, ‐14.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Level of pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.19 [‐1.82, ‐0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Hydrocolloid dressing vs silver sulphadiazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Polyurethane film dressing vs paraffin gauze dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.23, 6.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Polyurethane film dressing vs paraffin gauze dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Polyurethane film dressing vs chlorhexidine‐impregnated paraffin gauze dressing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 4.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Polyurethane film dressing vs chlorhexidine‐impregnated paraffin gauze dressing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Hydrogel dressing vs usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Wound healing: number of people healed at 6 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.46, 4.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Wound healing: number of people healed at 9 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [1.08, 3.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Wound healing: number of people healed at 21 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.95, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Wound healing: number of people healed at 12 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [1.17, 2.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Wound healing: number of people healed at 15 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.95, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Wound healing: number of people healed at 18 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.97, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Assessment of pain at baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pain 30 minutes after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.64, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Overall assessment of pain at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.31 [‐2.37, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Infection with Pseudomonas aeruginosa requiring antibiotic therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Hydrogel dressing vs usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Silicon nylon dressing vs silver sulphadiazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of dressing changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.49 [‐2.64, ‐0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Silicon nylon dressing vs silver sulphadiazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Biosynthetic skin substitute (Biobrane) vs silver sulphadiazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.20, ‐1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Need for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.21, 2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Biosynthetic skin substitute (Biobrane) vs silver sulphadiazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Antimicrobial‐releasing biosynthetic dressings vs silver sulphadiazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [0.87, 4.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Antimicrobial‐releasing biosynthetic dressings vs silver sulphadiazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Silver‐impregnated dressing vs silver sulphadiazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Wound healing time (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.22 [‐5.92, ‐2.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Wound healing: number of people healed at 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.58, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Wound healing: number of people healed at 10 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [0.97, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Wound healing: number of people healed at 15 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.02, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Wound healing: number of people healed at 17 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.98, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Wound healing: number of people healed at 21 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [1.06, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Healing rate (% wound area) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [‐2.37, 6.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.84 [‐5.89, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Need for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.21, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Number of infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.64, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Number of wound dressings <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.07 [‐19.58, ‐2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Nursing time (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.82 [‐19.42, 9.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Silver‐impregnated dressing vs silver sulphadiazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002106-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Fibre dressing vs silver sulphadiazine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Wound healing time (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.70 [‐5.44, ‐1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain at day 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.0 [‐3.03, ‐0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain at day 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.1 [‐4.02, ‐2.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain at day 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.4 [‐3.18, ‐1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of dressing changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.40 [‐15.66, ‐7.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.48, 3.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Need for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.24, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Fibre dressing vs silver sulphadiazine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002106.pub4/references#CD002106-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD002106.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD002106-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD002106-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD002106-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD002106-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD002106-note-0005">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD002106-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002106\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002106\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002106\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002106\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002106\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002106.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002106.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD002106.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD002106.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002106.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727733670"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002106.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727733673"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002106.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb348cea09368',t:'MTc0MDcyNzczNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 